<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4730335</article-id><article-id pub-id-type="doi">10.3390/ijms17010093</article-id><article-id pub-id-type="publisher-id">ijms-17-00093</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>miRNAs Regulation and Its Role as Biomarkers in Endometriosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mar&#x000ed;-Alexandre</surname><given-names>Josep</given-names></name><xref ref-type="aff" rid="af1-ijms-17-00093">1</xref><xref ref-type="author-notes" rid="fn1-ijms-17-00093">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;nchez-Izquierdo</surname><given-names>Dolors</given-names></name><xref ref-type="aff" rid="af2-ijms-17-00093">2</xref><xref ref-type="author-notes" rid="fn1-ijms-17-00093">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Gilabert-Estell&#x000e9;s</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="af3-ijms-17-00093">3</xref></contrib><contrib contrib-type="author"><name><surname>Barcel&#x000f3;-Molina</surname><given-names>Mois&#x000e9;s</given-names></name><xref ref-type="aff" rid="af1-ijms-17-00093">1</xref></contrib><contrib contrib-type="author"><name><surname>Braza-Bo&#x000ef;ls</surname><given-names>Aitana</given-names></name><xref ref-type="aff" rid="af1-ijms-17-00093">1</xref><xref rid="c1-ijms-17-00093" ref-type="corresp">*</xref><xref ref-type="author-notes" rid="fn2-ijms-17-00093">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Sandoval</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="af4-ijms-17-00093">4</xref><xref rid="c1-ijms-17-00093" ref-type="corresp">*</xref><xref ref-type="author-notes" rid="fn2-ijms-17-00093">&#x02021;</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Santanam</surname><given-names>Nalini</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Cho</surname><given-names>William Chi-shing</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-17-00093"><label>1</label>Unit of Hemostasia, Thrombosis, Atherosclerosis and Vascular Biology, Health Research Institute La Fe, Valencia 46026, Spain; <email>josepmarialexandre@gmail.com</email> (J.M.-A.); <email>moibarcelo@live.com</email> (M.B.-M.)</aff><aff id="af2-ijms-17-00093"><label>2</label>Arrays Unit, Health Research Institute La Fe, Valencia 46026, Spain; <email>Maria.D.Sanchez@uv.es</email></aff><aff id="af3-ijms-17-00093"><label>3</label>Maternal Child Area, General Hospital, Valencia 46014, Spain; <email>juangilaeste@yahoo.es</email></aff><aff id="af4-ijms-17-00093"><label>4</label>Epigomics Unit, Health Research Institute La Fe, Valencia 46026, Spain</aff><author-notes><corresp id="c1-ijms-17-00093"><label>*</label>Correspondence: <email>a.braza.boils@gmail.com</email> (A.B.-B.); <email>juan.sandoval@uv.es</email> (J.S.); Tel.: +34-96-124-6641 (A.B.-B.); +34-96-124-6709 (J.S.)</corresp><fn id="fn1-ijms-17-00093"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn><fn id="fn2-ijms-17-00093"><label>&#x02021;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2016</year></pub-date><volume>17</volume><issue>1</issue><elocation-id>93</elocation-id><history><date date-type="received"><day>21</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>08</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2016</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>MicroRNAs (miRNAs) are small non-coding RNAs (18&#x02013;22 nt) that function as modulators of gene expression. Since their discovery in 1993 in <italic>C. elegans</italic>, our knowledge about their biogenesis, function, and mechanism of action has increased enormously, especially in recent years, with the development of deep-sequencing technologies. New biogenesis pathways and sources of miRNAs are changing our concept about these molecules. The study of the miRNA contribution to pathological states is a field of great interest in research. Different groups have reported the implication of miRNAs in pathologies such as cancer, diabetes, cardiovascular, and gynecological diseases. It is also well-known that miRNAs are present in biofluids (plasma, serum, urine, semen, and menstrual blood) and have been proposed as ideal candidates as disease biomarkers. The goal of this review is to highlight the current knowledge in the field of miRNAs with a special emphasis to their role in endometriosis and the newest investigations addressing the use of miRNAs as biomarkers for this gynecological disease.</p></abstract><kwd-group><kwd>non-coding RNA</kwd><kwd>microRNA</kwd><kwd>biomarker</kwd><kwd>endometriosis</kwd></kwd-group></article-meta></front><body><sec id="sec1-ijms-17-00093"><title>1. Introduction</title><p>Traditionally, in all eukaryotic systems, genes codified proteins, following the central dogma of molecular biology [<xref rid="B1-ijms-17-00093" ref-type="bibr">1</xref>] consisting of DNA being transcribed into mRNA and mRNA translated into proteins. The first non-coding RNA (ncRNA) characterized was an alanine tRNA found in baker&#x02019;s yeast in 1965 [<xref rid="B2-ijms-17-00093" ref-type="bibr">2</xref>]. Since then, our understanding of the different and capital roles they play in cells and organisms development and functions has enormously increased. ncRNAs are also assumed to be genomic regulators at different levels and, in case of lower level of sequence conservation, are assumed as evolutionary and biodiversity repositories [<xref rid="B3-ijms-17-00093" ref-type="bibr">3</xref>].</p><p>Nowadays, it is evident that that RNA is not just a simple messenger between DNA and proteins but growing evidence supports new roles for these molecules, such as regulation of genome organization and gene expression. ncRNAs seem to act at many levels playing important roles in epigenetic processes by controlling differentiation and development and they have been related to very different pathologies (<xref ref-type="table" rid="ijms-17-00093-t001">Table 1</xref>). Short and long ncRNAs are key regulators of gene expression, genome stability, and defense against foreign genetic elements. ncRNAs are encoded in the genome and never become proteins, demonstrating that the first assumed functions for those molecules have been a lot less than expected [<xref rid="B4-ijms-17-00093" ref-type="bibr">4</xref>].</p><table-wrap id="ijms-17-00093-t001" position="float"><object-id pub-id-type="pii">ijms-17-00093-t001_Table 1</object-id><label>Table 1</label><caption><p>Classes of non-coding RNAs (ncRNA).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Symbol</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Non-Coding RNAs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Functions</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">tRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Transfer RNA</td><td align="center" valign="middle" rowspan="1" colspan="1">mRNA translation (structural)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">rRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Ribosomal RNA</td><td align="center" valign="middle" rowspan="1" colspan="1">mRNA translation (structural)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">miRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">micro RNAs</td><td align="center" valign="middle" rowspan="1" colspan="1">Post-transcriptional transposon repression</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">piRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Piwi-interacting RNA</td><td align="center" valign="middle" rowspan="1" colspan="1">DNA methylation, transposon repression</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">siRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Short interfering RNA</td><td align="center" valign="middle" rowspan="1" colspan="1">RNA interference</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">snoRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Small nucleolar RNAs</td><td align="center" valign="middle" rowspan="1" colspan="1">RNA modification, rRNA processing</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PROMPT&#x02019;s</td><td align="center" valign="middle" rowspan="1" colspan="1">Promoter upstream transcripts</td><td align="center" valign="middle" rowspan="1" colspan="1">Associated with chromatin changes</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">tiRNAs</td><td align="center" valign="middle" rowspan="1" colspan="1">Transcripton initation RNAs</td><td align="center" valign="middle" rowspan="1" colspan="1">Epigenetic regulation</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">lincRNAs</td><td align="center" valign="middle" rowspan="1" colspan="1">Long intergenic ncRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Epigenetic regulators of transcription</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">rasiRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Repeat associated small interfering RNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Involved in the RNA interference (RNAi) pathway</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">eRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhancer-like ncRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Transcriptional gene activation</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T-UCRs</td><td align="center" valign="middle" rowspan="1" colspan="1">Transcribed ultraconserved regions</td><td align="center" valign="middle" rowspan="1" colspan="1">Regulation of miRNA and mRNA levels</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NATs</td><td align="center" valign="middle" rowspan="1" colspan="1">Natural antisense transcripts</td><td align="center" valign="middle" rowspan="1" colspan="1">mRNA stability</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PALRs</td><td align="center" valign="middle" rowspan="1" colspan="1">Promoter-associated long RNAs</td><td align="center" valign="middle" rowspan="1" colspan="1">Chromatin changes</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">tasiRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Trans-acting siRNA</td><td align="center" valign="middle" rowspan="1" colspan="1">Represses gene expression</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">lncRNA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Long noncoding RNA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulation of gene transcription</td></tr></tbody></table></table-wrap></sec><sec id="sec2-ijms-17-00093"><title>2. Non-Coding RNA Identification: The ENCODE Project</title><p>ncRNAs are RNA fragments that are transcribed from DNA but are not translated into proteins. The main function of ncRNAs is to regulate gene expression at the transcriptional and post-transcriptional level. ncRNAs can be divided into structural and functional regulatory ncRNAs and, at the same time, functional ncRNAs can be subdivided into two main groups according their length; the short ncRNAs (&#x0003c;30 nts) and the long ncRNAs (&#x0003e;200 nts). The amount of ncRNAs codified in the human genome is unknown; however, recent bioinformatic studies have described the sequence of thousands of them [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>]. ncRNAs genes include those that are extremely high expressed and showing essential cell functions such as <xref ref-type="table" rid="ijms-17-00093-t001">Table 1</xref> describes. A huge contribution to the identification of untranslated sequences has been the ENcyClopedia of DNA Elements (ENCODE <uri xlink:type="simple" xlink:href="http://www.genome.gov/encode/">http://www.genome.gov/encode/</uri>), released in September 2003. The conclusions from this pilot project were published in June 2007 [<xref rid="B6-ijms-17-00093" ref-type="bibr">6</xref>]. ENCODE Project was focused on defining RNA transcripts, transcriptional regulator binding sites, and chromatin states in many cell types by different approaches: (a) genomics, to find functional elements where mutations and knock-down models demonstrate the phenotype associated to the genomic sequence; (b) evolutive conservation, as indicator of functional sequences and (c) biochemical approach in models, to characterize ncRNA activity in specific cell type, condition, and molecular processes [<xref rid="B7-ijms-17-00093" ref-type="bibr">7</xref>]. Bioinformatic studies on gene regulation and RNA metabolism have described a new variety of functional non-coding sequences, including promoters, enhancers, silencers, insulators, and ncRNA genes. These non-coding elements are associated with chromatin structures or transcription enhancers displaying, for example, histone modifications, DNA methylation, DNase and transcription factor accessibility [<xref rid="B8-ijms-17-00093" ref-type="bibr">8</xref>,<xref rid="B9-ijms-17-00093" ref-type="bibr">9</xref>,<xref rid="B10-ijms-17-00093" ref-type="bibr">10</xref>,<xref rid="B11-ijms-17-00093" ref-type="bibr">11</xref>,<xref rid="B12-ijms-17-00093" ref-type="bibr">12</xref>,<xref rid="B13-ijms-17-00093" ref-type="bibr">13</xref>]. Some of them could be considered at some point as &#x02018;structural sequences&#x02019;. YRNAs, for instance, are stem loops essential for DNA replication interacting with chromatin and initiation proteins (including the origin recognition complex) [<xref rid="B14-ijms-17-00093" ref-type="bibr">14</xref>,<xref rid="B15-ijms-17-00093" ref-type="bibr">15</xref>]. Small RNAs are able to modify chromatin structure and to silence transcription by guiding Argonaute-containing complexes to complementary newly transcribed RNAs scaffolds or to gene promoters [<xref rid="B16-ijms-17-00093" ref-type="bibr">16</xref>], mediating histone and DNA methyltransferases recruitment. </p></sec><sec id="sec3-ijms-17-00093"><title>3. miRNAs</title><p>In 1993, a new possibility was included in the genomic and regulatory scheme. Victor Ambros, Rosalind Lee, and Rhonda Feinbaum, during a study of the lin-4 gene controlling the timing of <italic>Caenorhabditiselegans</italic> larval development, described the first miRNA repressing the lin-14 gene [<xref rid="B17-ijms-17-00093" ref-type="bibr">17</xref>]. miRNAs are small (21&#x02013;22 nts) ncRNAs that regulate gene expression and play fundamental regulatory roles in many biological processes [<xref rid="B18-ijms-17-00093" ref-type="bibr">18</xref>,<xref rid="B19-ijms-17-00093" ref-type="bibr">19</xref>,<xref rid="B20-ijms-17-00093" ref-type="bibr">20</xref>]. miRNAs can inhibit the translation of hundreds of mRNAs through sequence specific recognition to the &#x0201c;seed sequence&#x0201d;, and according to the degree of nucleotide compliment, will raise the inhibition of translation and/or degradation of target molecule of mRNAs [<xref rid="B18-ijms-17-00093" ref-type="bibr">18</xref>,<xref rid="B19-ijms-17-00093" ref-type="bibr">19</xref>,<xref rid="B20-ijms-17-00093" ref-type="bibr">20</xref>,<xref rid="B21-ijms-17-00093" ref-type="bibr">21</xref>]. Functional analysis of miRNAs have revealed their significant regulatory influence on the expression of target genes involved in both physiological and pathological conditions including gynecological diseases such as endometriosis [<xref rid="B22-ijms-17-00093" ref-type="bibr">22</xref>,<xref rid="B23-ijms-17-00093" ref-type="bibr">23</xref>,<xref rid="B24-ijms-17-00093" ref-type="bibr">24</xref>,<xref rid="B25-ijms-17-00093" ref-type="bibr">25</xref>,<xref rid="B26-ijms-17-00093" ref-type="bibr">26</xref>,<xref rid="B27-ijms-17-00093" ref-type="bibr">27</xref>,<xref rid="B28-ijms-17-00093" ref-type="bibr">28</xref>].</p></sec><sec id="sec4-ijms-17-00093"><title>4. miRNAs Biogenesis</title><p>miRNA genes are mainly codified in intergenic or intronic regions of their target genes. In these cases a miRNA gene is transcribed together with its host gene providing a coupled regulation of both. Some pri-miRNA may be codified in the intronic regions of protein and non-protein coding genes or in exons of long non-protein coding RNAs. Consequently, the expression of these miRNAs could be regulated with their host genes [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>]. Other miRNA genes show a common promoter forming polycistronic units, containing multiple discrete loops from which mature miRNAs are processed.</p><p>In the canonical miRNA biogenesis pathways described in <xref ref-type="fig" rid="ijms-17-00093-f001">Figure 1</xref>, pri-miRNAs are trimmed by the RNAse III Drosha with the help of a double-stranded RNA binding protein: DGCR8. This protein-complex is known as the Microprocessor and yields ~70 nt stem-loop precursors, termed pre-miRNA, with two nucleotides overhanging at the 3&#x02019; and a 5&#x02019;-phospate. The pre-miRNA is then translocated to the cytoplasm by Exportin-5, a Ran-GTP dependent protein [<xref rid="B29-ijms-17-00093" ref-type="bibr">29</xref>,<xref rid="B30-ijms-17-00093" ref-type="bibr">30</xref>]. From this point on, further steps are common for miRNAs and exogenous siRNAs.</p><p>Once in the cytoplasm, the pre-miRNA is trimmed by Dicer, an RNAse III enzyme, in combination with TRBP (transactivation Response RNA-Binding Protein) [<xref rid="B31-ijms-17-00093" ref-type="bibr">31</xref>]. As a consequence, the loop sequence of the hairpin is released and Dicer renders a ~22 nt RNA-duplex with short 3&#x02019; overhangs. This step defines the 3&#x02019; end of the 5&#x02019; strand and the 5&#x02019; end of the 3&#x02019; strand [<xref rid="B18-ijms-17-00093" ref-type="bibr">18</xref>]. Then, Dicer transfers the RNA-duplex to an Ago (Argonaute) protein, which forms the nucleus of RISC (RNA-Induced Silencing Complex). At this time, the complex is called the pre-RISC. The mature RISC is achieved once one of the two strands of the duplex is removed; a process termed &#x0201c;strand selection&#x0201d;.</p><p>The main determinant of this process seems to be a thermodynamic factor, mainly determined by the first four nucleotides of the duplex. Hence, the end with weaker interactions will preferentially unwind and remain as the &#x0201c;guide strand&#x0201d;, while the so called &#x0201c;passenger strand&#x0201d; will be discarded [<xref rid="B30-ijms-17-00093" ref-type="bibr">30</xref>].</p><p>The mature RISC complex is able to scan the cytoplasm searching for mRNA able to pair with the loaded miRNA. The miRNA:mRNA pairing is defined by Watson-Crick interactions between the 3&#x02019; UTR (untranslated region) of the mRNA and a short region of nucleotides in positions 2 to 8 of the miRNA known as the &#x0201c;seed sequence&#x0201d;. It is worthy to mention that beyond this general principle of miRNA:mRNA interaction, miRNA pairing with the 5&#x02019; UTR has also been defined and observed to be of clinical interest [<xref rid="B31-ijms-17-00093" ref-type="bibr">31</xref>] and that additional nucleotides outside the seed sequence can also contribute to determine the mRNA fate [<xref rid="B18-ijms-17-00093" ref-type="bibr">18</xref>]. </p><p>It is important to highlight that the DNA sequence is not always the template for the mature miRNA : 6% of human miRNAs suffer RNA editing. In other words, a single pre-miRNA can become multiple mature miRNAs that differ in their length and sequence, named isomiR. The editing process can alter the &#x0201c;seed sequence&#x0201d; conferring different affinity for other targets, modifying the mRNA target selection [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>,<xref rid="B32-ijms-17-00093" ref-type="bibr">32</xref>]. In this context, the cell-specific expression of different isomiRs implies different protein expression depending on the cell type conferring the biological significance of these miRNA variants. This phenomenon increases the spectrum of miRNA action.</p><fig id="ijms-17-00093-f001" position="float"><label>Figure 1</label><caption><p>Schematic description of miRNAs biogenesis.</p></caption><graphic xlink:href="ijms-17-00093-g001"/></fig><p>Silencing of mRNAs can be achieved by means of mRNA cleavage or translational repression. Perfect miRNA:mRNA pairing leads to Ago cutting of mRNA approximately at the middle of the miRNA length, whereas imperfect pairing mediates mRNA translational repression by different mechanisms [<xref rid="B18-ijms-17-00093" ref-type="bibr">18</xref>].</p><p>Apart from the canonical miRNA biogenesis pathway, intronic miRNAs can undergo the &#x0201c;mirtron pathway&#x0201d;. In this non-canoncial biogenesis pathway, the spliced intron renders a lariat in which the 3&#x02019; brachpoint is ligated to the 5&#x02019; end of the intron. Following the action of Ldbr (lariat debranching enzyme) the lariat is converted in a pre-miRNA that can enter the canonical miRNA biogenesis pathway [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>,<xref rid="B33-ijms-17-00093" ref-type="bibr">33</xref>]. As the vast majority of intronic miRNAs are found on the sense strand it seems plausible that their expression may be related to that of the host mRNA [<xref rid="B34-ijms-17-00093" ref-type="bibr">34</xref>,<xref rid="B35-ijms-17-00093" ref-type="bibr">35</xref>] in terms of tissue specificity and relative amount [<xref rid="B36-ijms-17-00093" ref-type="bibr">36</xref>].</p><p>With the avenue of deep-sequencing strategies, the field of miRNAs research has experienced an unprecedented growth in terms of genetic origins, biosynthetic pathways, and sequence variants [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>]. As a result, several ncRNAs have been identified as sources of miRNAs, including snoRNA, lncRNA, and tRNA genes with Drosha- and/or Dicer-independent biogenesis [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>].</p></sec><sec id="sec5-ijms-17-00093"><title>5. miRNAs Nomenclature</title><p>The recent advances in high-throughput sequences applied to the miRNA discovery have enormously challenged criteria for miRNA annotation. Nomenclature rules are currently defined by miRBase 21 [<xref rid="B37-ijms-17-00093" ref-type="bibr">37</xref>] and the mature form of the miRNA fit the form hsa-miR-XX-3p/5p, where the prefix refers to the species (e.g., hsa- for Homo sapiens). When it is written in capitalized letters, &#x0201c;MIR&#x0201d;, refers to the gene that encodes them; and pre-miRNA and pri-miRNA are named as &#x0201c;mir-&#x0201d;. Distinct precursor sequences and genomic loci expressing identical mature sequences get names of the form hsa-mir-121-1 and hsa-mir-121-2 and adding letters as suffixes denotes mature sequences closely related (hsa-miR-121a and hsa-miR-121b) named miR families. Cloning studies sometimes identify two mature sequences originated from the same pre-miRNA. The ratio between the two opposite mature strands can vary depending on developmental stage, being differentially expressed in distinct tissues or cell types, as well as in pathological conditions [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>,<xref rid="B30-ijms-17-00093" ref-type="bibr">30</xref>]. Previous nomenclature versions identified the less expressed strand as asterisk * (hsa-miR-XX *). However, recent studies have demonstrated that both strands are functional and the ratio between strands depends on the cellular type or status, the annotation criteria was appropriately changed to the current 5p-/3p-end. Apart from the aforementioned miRNA nomenclature, miRBase also identifies mature miRNAs with a MIMAT accession number. From our own experience, we do recommend authors to refer to studied miRNAs in their manuscripts with the current -3p or -5p suffix and also to include the miRBase MIMAT reference and oligonucleotide sequence in order to avoid future misunderstanding that further nomenclature modifications could introduce. </p><p>In the light of current discoveries in miRNA origins, biosynthetic pathways, and sequence variants, Desvignes and co-workers proposed a revised miRNA nomenclature criterion in the aim of encompassing recent findings in the field. The authors proposed to modify the miRNA nomenclature not only based on biogenesis but also on their function [<xref rid="B5-ijms-17-00093" ref-type="bibr">5</xref>].</p></sec><sec id="sec6-ijms-17-00093"><title>6. Studying miRNAs</title><p>In a classic study of miRNAs, the first aim is to assess the miRNA expression profile comparing a pathological group to a control one. The second step in order to corroborate the profiling results is to validate the expression of some of selected miRNAs in a larger cohort of samples. Finally, it would be interesting to prepare functional assays in order to validate the regulation of a specific mRNA translation by the selected miRNA. Summary of technologies applied in miRNA discovering are listed in <xref ref-type="fig" rid="ijms-17-00093-f002">Figure 2</xref>.</p><p>The most employed techniques in order to assess miRNA expression profiles are next generation sequencing and microarrays.</p><fig id="ijms-17-00093-f002" position="float"><label>Figure 2</label><caption><p>Workflow in a classical study on miRNAs.</p></caption><graphic xlink:href="ijms-17-00093-g002"/></fig><sec id="sec6dot1-ijms-17-00093"><title>6.1. RNA Sequencing</title><p>Next Generation Sequencing (NGS) was initially developed for sequencing genes faster, cheaper and deeper. The ability to read millions of short fragments of DNA was soon moved into a new methodology, RNAseq, which includes RNA sequencing and quantification. Total RNA from samples is digested and retrotrasncribed through ligation of universal primers. cDNA products are then ligated to primer adaptors for NGS and amplified and isolated in single sequencing reactions on a surface containing millions of &#x0201d;nanopore&#x0201d; sequencing reactors. Second generation sequencers are able to detect millions of isolated sequencing reactions and to generate data related to nucleotide sequences and the number of reads of each sequence. The bioinformatic software associated with the NGS sequencer is able to align each short RNA fragment with their corresponding genomic region, building a complete transcript read. Analogous to qPCR, the number of reads obtained in RNAseq protocols is correlated to the original amount of cell RNA together with sequence variant detected in the alignment. As limitations, the sensibility of NGS is linked to coverage and throughput, so the presence of over-expressed miRNAs can reduce the ability for detecting miRNAs very low expressed.</p></sec><sec id="sec6dot2-ijms-17-00093"><title>6.2. miRNA Microarrays</title><p>Microarrays have been a revolution in genomic and proteomics fields because of their ability to simultaneously detect thousands of molecules. Thereafter, expression assessment moved from particular genes to whole genomic profiles in which miRNA profiles helped to decode the real complexity of pathological models [<xref rid="B38-ijms-17-00093" ref-type="bibr">38</xref>]. Microarray technology is based on the link of millions of genomic fragments on a glass support that are used for sample hybridization (Affymetrix, Agilent, Illumina, NanoString). Samples are fluorescently labeled prior to hybridization. Thus, relative signal on each probe reflects the original amount of miRNA in the studied sample. Hundreds of new ncRNAs are described on an annual basis. For this reason, updating and re-designing of non-coding RNA microarray platforms is mandatory. miRNA expression profiles obtained from microarray platforms should be validated by qPCR in a larger number of samples.</p><p>Both techniques have demonstrated their ability in measuring a large number of miRNAs, generating a wide amount of results in the discovery phase. However, nowadays the economic cost is still too expensive to employ them in the validation step. Therefore, quantitative PCR is confirmed to be the most accurate technique to validate results from RNAseq or microarrays</p></sec><sec id="sec6dot3-ijms-17-00093"><title>6.3. Quantitative PCR or Real-Time PCR</title><p>Quantitative PCR (qPCR) or Real-Time PCR (RT-PCR) is a fast, easy, and affordable technique for quantification of miRNAs. Different names depend on applications or thermocycler platforms employed. PCR allows working with very few amount of starting RNA. The first step consists in the synthesis of complementary DNA to miRNA through an adapter following a retrotranscription protocol (RT-PCR). The exponential amplification process in RT-PCR is an extremely sensitive and accurate method for detecting molecules at very low level, thus becoming the gold standard method for quantification of miRNAs in biofluids such as plasma or serum. Few limitations can be attributed to this technique, for example, the limited number of molecules detected depending on plate design (96- or 384-well plate). Pre-amplification and amplification increase sensitivity quantification can be biased in low expressed sequences due to diverse protocol steps. On the other hand, normalization can be difficult because, commonly, &#x0201c;housekeeping&#x0201d; molecules that are used as normalizers can be not stably expressed in some models or pathologies. In any case, so far, qPCR is the reference method for expression validation of other techniques in miRNA research [<xref rid="B39-ijms-17-00093" ref-type="bibr">39</xref>]. Nowadays, some high-throughput PCR designed plates are called arrays (Applied, Qiagen, Exiqon). These plates include a customized selection of probes ready-to-use in order to quantify a high number of miRNAs from a single sample reducing technical variations.</p></sec><sec id="sec6dot4-ijms-17-00093"><title>6.4. In Situ Hybridization (ISH) and Live Cell miRNA Detection</title><p>Some companies already specialized in miRNA detection have also developed fluorescent or antibody-conjugated colored-coupled probes for <italic>in situ</italic> miRNA detection (Exiqon, Merk-Millipore). These methodologies allow localizing miRNA molecules in cells or tissues, helping to better characterization of its biogenesis, pathways, and activity. Fluorescent-labeled probes show miRNA localization in fixed or live cells and allow, in some assays, to perform flow sorting of cells expressing concrete regulators [<xref rid="B40-ijms-17-00093" ref-type="bibr">40</xref>]. During ISH, a locked nucleic acid (LNA) probe hybridizes to the target sequence at elevated temperature, and then the excess probe is washed away. LNA probes are highly sensitive and have been assayed for therapeutically miRNA antisense therapies [<xref rid="B41-ijms-17-00093" ref-type="bibr">41</xref>]. </p></sec></sec><sec id="sec7-ijms-17-00093"><title>7. miRNAs as Biomarkers</title><p>&#x0201c;Biomarker&#x0201d; definition has been revised by the Biomarker Definitions Working Group in 2001 [<xref rid="B42-ijms-17-00093" ref-type="bibr">42</xref>] as &#x0201c;a characteristic that is objectively measured and evaluated as an indication of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention&#x0201d;. In the &#x0201c;omics&#x0201d; era biomarkers can include clinical scoring systems, proteins, gene expression measurements of mRNA, miRNA, DNA, genetic variants of DNA, or metabolites [<xref rid="B43-ijms-17-00093" ref-type="bibr">43</xref>].</p><p>With the aim to better understand the pathophysiology of different diseases, several authors have reported miRNA expression profiles characteristic of some pathologies (cardiovascular diseases, cancer, diabetes, sepsis, gynecological diseases) [<xref rid="B25-ijms-17-00093" ref-type="bibr">25</xref>,<xref rid="B26-ijms-17-00093" ref-type="bibr">26</xref>,<xref rid="B28-ijms-17-00093" ref-type="bibr">28</xref>,<xref rid="B44-ijms-17-00093" ref-type="bibr">44</xref>,<xref rid="B45-ijms-17-00093" ref-type="bibr">45</xref>]. The first approach to define a pathological miRNA expression profile is to assess the miRNA expression pattern in the pathological tissue in order to clarify the molecular mechanisms underlying the disease. In this context, miRNAs have reportedly been found in different body fluids, from urine, serum, and plasma to cerebrospinal fluid [<xref rid="B46-ijms-17-00093" ref-type="bibr">46</xref>,<xref rid="B47-ijms-17-00093" ref-type="bibr">47</xref>].</p><p>The presence of miRNAs in different biofluids could be explained by different mechanisms [<xref rid="B39-ijms-17-00093" ref-type="bibr">39</xref>,<xref rid="B43-ijms-17-00093" ref-type="bibr">43</xref>,<xref rid="B48-ijms-17-00093" ref-type="bibr">48</xref>,<xref rid="B49-ijms-17-00093" ref-type="bibr">49</xref>]: (a) passive release of miRNAs as consequence of tissue injury, chronic inflammation, cell apoptosis or necrosis, or from cells with a short half-life, such as platelets; (b) active secretion via cell-derived microvesicles including exosomes microparticles and apoptotic bodies [<xref rid="B50-ijms-17-00093" ref-type="bibr">50</xref>,<xref rid="B51-ijms-17-00093" ref-type="bibr">51</xref>,<xref rid="B52-ijms-17-00093" ref-type="bibr">52</xref>]; (c) active secretion by cells in miRNA-protein complexes: High Density Lipoprotein (HDL) and Low Density Lipoprotein (LDL) [<xref rid="B53-ijms-17-00093" ref-type="bibr">53</xref>] and Ago2 [<xref rid="B54-ijms-17-00093" ref-type="bibr">54</xref>]. Interestingly, Arroyo and co-workers suggested that Ago2-associated miRNAs could be ready to regulate gene expression in recipient cells [<xref rid="B54-ijms-17-00093" ref-type="bibr">54</xref>]. Mechanisms (b) and (c) could also offer a rationale for the elevated stability of miRNAs in an RNAse-rich circulation [<xref rid="B49-ijms-17-00093" ref-type="bibr">49</xref>]. In light of this evidence, some authors proposed an hormone-like mechanism of action for these miRNAs [<xref rid="B48-ijms-17-00093" ref-type="bibr">48</xref>,<xref rid="B49-ijms-17-00093" ref-type="bibr">49</xref>] and a role into cell-to-cell communication [<xref rid="B55-ijms-17-00093" ref-type="bibr">55</xref>,<xref rid="B56-ijms-17-00093" ref-type="bibr">56</xref>,<xref rid="B57-ijms-17-00093" ref-type="bibr">57</xref>,<xref rid="B58-ijms-17-00093" ref-type="bibr">58</xref>].</p><p>Circulating miRNAs, such as the miRNAs released by cancer cells, can bind to Toll-like receptors (TLRs) of immune cells, such as TLR7 in mice or TLR8 in human, to activate NF&#x003ba;B [<xref rid="B59-ijms-17-00093" ref-type="bibr">59</xref>,<xref rid="B60-ijms-17-00093" ref-type="bibr">60</xref>]. This mechanism could partially explain inflammation related to cancer. </p><p>Importantly, Mitchell and co-workers showed the potential of blood miRNAs as biomarkers for prostate cancer [<xref rid="B61-ijms-17-00093" ref-type="bibr">61</xref>], paving the way for further characterizations in other pathologies. In addition, the authors demonstrated that miRNAs were protected from endogenous RNAse activity [<xref rid="B61-ijms-17-00093" ref-type="bibr">61</xref>].</p></sec><sec id="sec8-ijms-17-00093"><title>8. miRNAs Role in Endometriosis</title><p>Different groups, including ours, have studied the potential role of miRNAs in the endometriosis development over years. miRNAs raise as potent regulators of gene expression in the most important systems involved in the pathogenesis of endometriosis. As <xref ref-type="fig" rid="ijms-17-00093-f003">Figure 3</xref> details, cell survival, matrix remodeling, proliferation, and angiogenesis are essential systems in the pathophysiology of this disease and all of them are potentially regulated by miRNAs [<xref rid="B21-ijms-17-00093" ref-type="bibr">21</xref>,<xref rid="B22-ijms-17-00093" ref-type="bibr">22</xref>,<xref rid="B25-ijms-17-00093" ref-type="bibr">25</xref>,<xref rid="B28-ijms-17-00093" ref-type="bibr">28</xref>,<xref rid="B62-ijms-17-00093" ref-type="bibr">62</xref>].</p></sec><sec id="sec9-ijms-17-00093"><title>9. Endometriosis</title><p>Endometriosis is a benign estrogen-dependent inflammatory disorder characterized by the presence of endometrial-like tissue outside the uterus. Endometriosis-lesions can be found on the peritoneum (peritoneal lesions), on the ovary either as superficial implants or as endometriotic cysts, and as deeply infiltrative lesions that might extend to the bowel, bladder, and ureter. Pelvic adhesions are often associated with the aforementioned lesions [<xref rid="B63-ijms-17-00093" ref-type="bibr">63</xref>]. These lesions are responsible for the main symptoms of endometriosis, pelvic pain and infertility [<xref rid="B64-ijms-17-00093" ref-type="bibr">64</xref>]. Whereas innervation at the site of endometriotic lesions is involved in pelvic pain [<xref rid="B65-ijms-17-00093" ref-type="bibr">65</xref>], inflammation has been also associated with infertility, what could be explained by a diminished oocyte quality because if their development in an unfavorable environment [<xref rid="B66-ijms-17-00093" ref-type="bibr">66</xref>] and also a compromised endometrial receptivity [<xref rid="B67-ijms-17-00093" ref-type="bibr">67</xref>].</p><p>Endometriosis has been classified as a tumor-like condition by the World Health Organization Histologic Classification of Ovarian Tumors [<xref rid="B68-ijms-17-00093" ref-type="bibr">68</xref>]. Indeed, endometriosis shares common features with cancer, as increased local estrogen production, reduced apoptosis, pro-survival, inflammation, tissue invasion, induction of angiogenesis, and dysfunction of immune cells [<xref rid="B69-ijms-17-00093" ref-type="bibr">69</xref>]. Since Sampson reported the first case of suspected malignant transformation of ovarian endometriosis [<xref rid="B70-ijms-17-00093" ref-type="bibr">70</xref>], several studies have focused on the relationship between endometriosis and gynecological cancers, especially endometrioid and clear cell ovarian carcinoma [<xref rid="B71-ijms-17-00093" ref-type="bibr">71</xref>,<xref rid="B72-ijms-17-00093" ref-type="bibr">72</xref>,<xref rid="B73-ijms-17-00093" ref-type="bibr">73</xref>,<xref rid="B74-ijms-17-00093" ref-type="bibr">74</xref>]. However, in a recent review, Guo pointed that existing data is not enough to establish a doubtless causality and highlighted the need for further molecular studies in order to establish an unequivocal phylogenetic relationship between both conditions [<xref rid="B69-ijms-17-00093" ref-type="bibr">69</xref>].</p><p>Despite its high prevalence and incapacitating symptoms, the exact etiopathogenic mechanism of endometriosis remains unsolved. Burney and Giudice reviewed the theories purposed in recent years with the aim of providing a plausible etiopathogenic mechanism for endometriosis [<xref rid="B75-ijms-17-00093" ref-type="bibr">75</xref>]. However, nowadays, the most accepted theory is by far Sampson&#x02019;s retrograde menstruation proposal, which points that during menstruation, endometrial fragments could migrate through fallopian tubes and reach the peritoneum, being capable to attach, survive, and implant at different locations [<xref rid="B70-ijms-17-00093" ref-type="bibr">70</xref>]. It has been demonstrated that all these mechanisms responsible for endometriosis development can be regulated by miRNAs as <xref ref-type="fig" rid="ijms-17-00093-f003">Figure 3</xref> shows.</p></sec><sec id="sec10-ijms-17-00093"><title>10. Studying New Biomarkers of Endometriosis</title><p>The current gold standard for the diagnosis of endometriosis is laparoscopic examination with histological confirmation of glands and/or stroma in the excised lesions [<xref rid="B76-ijms-17-00093" ref-type="bibr">76</xref>]. The need for surgical procedure for diagnosis together with the fear of a cancer diagnosis and the assumption of dysmenorrhea as a normal event could explain the aforementioned delay in time to diagnosis [<xref rid="B77-ijms-17-00093" ref-type="bibr">77</xref>]. Taking into account that endometriosis has been reported to be progressive in up to 50% of women [<xref rid="B78-ijms-17-00093" ref-type="bibr">78</xref>] and more advanced in women with delayed diagnosis [<xref rid="B79-ijms-17-00093" ref-type="bibr">79</xref>] efforts are conducted to achieve a noninvasive diagnosis. In this context, several approaches have been undertaken, such as symptom-based tests [<xref rid="B80-ijms-17-00093" ref-type="bibr">80</xref>], or blood tests [<xref rid="B81-ijms-17-00093" ref-type="bibr">81</xref>,<xref rid="B82-ijms-17-00093" ref-type="bibr">82</xref>,<xref rid="B83-ijms-17-00093" ref-type="bibr">83</xref>], but so far neither a non-invasive nor a minimally invasive test has been achieved, remaining as a priority in endometriosis research [<xref rid="B84-ijms-17-00093" ref-type="bibr">84</xref>]. Therefore, an ideal test for diagnosis of endometriosis should diagnose patients at initial stages with high sensitivity and specificity.</p><p>Due to the anatomical location of this condition, several closely related biofluids have been proposed as a source for noninvasive biomarkers of endometriosis, for instance: urine, plasma/serum, and menstrual blood. In addition, the finding that retrograde menstruation is present in 90% of women but not all of them suffer from endometriosis [<xref rid="B67-ijms-17-00093" ref-type="bibr">67</xref>,<xref rid="B85-ijms-17-00093" ref-type="bibr">85</xref>] suggests that molecular differences between eutopic endometrium from women with and without endometriosis may exist that lead to the development of the condition in certain women but not in others [<xref rid="B67-ijms-17-00093" ref-type="bibr">67</xref>]. As a consequence, if these molecular differences were found to be pathognomonic of the condition they could also provide an opportunity to be considered as biomarkers in biopsied tissues obtained via a minimally invasive procedure.</p><p>In the field of miRNAs, differences in miRNA expression between endometriotic lesions and eutopic endometrium from women with endometriosis have been reported [<xref rid="B27-ijms-17-00093" ref-type="bibr">27</xref>,<xref rid="B86-ijms-17-00093" ref-type="bibr">86</xref>] but few studies have focused in differences between eutopic endometrium from women with and without endometriosis [<xref rid="B21-ijms-17-00093" ref-type="bibr">21</xref>,<xref rid="B27-ijms-17-00093" ref-type="bibr">27</xref>,<xref rid="B87-ijms-17-00093" ref-type="bibr">87</xref>].</p><p>Burney <italic>et al.</italic> published one of the first studies addressing the miRNA expression profile in the endometrium of women with and without endometriosis [<xref rid="B21-ijms-17-00093" ref-type="bibr">21</xref>]. In this study, miRNA arrays were performed and after qRT-PCR validation, the authors reported a downregulation of four miRNAs (miR-34c-5p, miR-9, miR-9 *, miR-34b *) in the eutopic endometrium from women with endometriosis compared to control endometrium. According to the miRNA regulatory mechanisms, downregulated levels of a miRNA entails the upregulation of its target mRNA translation. Laudanski <italic>et al.</italic> conducted a study enrolling 25 endometriosis-free women and 21 patients with ovarian endometriosis in which the expression of 667 human miRNAs was examined by means of PCR arrays. Validation of the results led to the corroboration that miR-483-5p, a regulator of IGF2, and miR-629-3p, involved in inflammation, were downregulated in the eutopic endometrium of patients in comparison to controls. The authors pointed to the idea that dysregulation of these genes could contribute to the overgrowth of endometrial tissue outside the uterus [<xref rid="B87-ijms-17-00093" ref-type="bibr">87</xref>].</p><p>Human endometrium is a unique tissue that undergoes complex molecular, cellular, and functional changes on a cyclic basis under ovarian hormone regulation [<xref rid="B88-ijms-17-00093" ref-type="bibr">88</xref>,<xref rid="B89-ijms-17-00093" ref-type="bibr">89</xref>,<xref rid="B90-ijms-17-00093" ref-type="bibr">90</xref>]. These changes are essential for uterine receptivity and can be grouped in three distinct phases: proliferative, secretory, and menstrual [<xref rid="B90-ijms-17-00093" ref-type="bibr">90</xref>]. Some authors have described that miRNA expression vary across the menstrual cycle [<xref rid="B24-ijms-17-00093" ref-type="bibr">24</xref>]. Particularly, miRNAs targeting several cell cycle regulators were over-expressed in the secretory phase [<xref rid="B23-ijms-17-00093" ref-type="bibr">23</xref>]. </p><p>Angiogenesis also plays an important role in the pathogenesis of endometriosis, due that ectopic lesions require neovascularization to proliferate, invade the extracellular matrix and proliferate [<xref rid="B27-ijms-17-00093" ref-type="bibr">27</xref>,<xref rid="B28-ijms-17-00093" ref-type="bibr">28</xref>,<xref rid="B91-ijms-17-00093" ref-type="bibr">91</xref>]. Both Vascular Endothelial Growth Factor A (VEGF-A) and Thrombospondin-1 (TSP-1) represent the most potent pro- and anti-angiogenic factors, respectively, and have been involved in the pathology of endometriosis [<xref rid="B92-ijms-17-00093" ref-type="bibr">92</xref>]. Our research group has reportedly observed an increase in the expression of angiogenic and proteolytic factors in endometrial tissues from patients with endometriosis [<xref rid="B93-ijms-17-00093" ref-type="bibr">93</xref>,<xref rid="B94-ijms-17-00093" ref-type="bibr">94</xref>] and we have suggested that this increase might contribute to the invasive potential of endometrial cells.</p><p>The miRNA regulation of angiogenesis has been long reported in several pathologies, including endometriosis [<xref rid="B27-ijms-17-00093" ref-type="bibr">27</xref>,<xref rid="B28-ijms-17-00093" ref-type="bibr">28</xref>,<xref rid="B86-ijms-17-00093" ref-type="bibr">86</xref>,<xref rid="B87-ijms-17-00093" ref-type="bibr">87</xref>,<xref rid="B95-ijms-17-00093" ref-type="bibr">95</xref>,<xref rid="B96-ijms-17-00093" ref-type="bibr">96</xref>]. Two different groups have reported that the angiogenesis regulators, miR-17-5p and miR-20a, are downregulated in the ovarian endometrioma compared to eutopic endometrium [<xref rid="B24-ijms-17-00093" ref-type="bibr">24</xref>,<xref rid="B87-ijms-17-00093" ref-type="bibr">87</xref>]. The miR-17-92 cluster, also known as oncomir-1, encodes six mature miRNAs (miR-17, miR-18a, miR-19a, miR-19b, miR-20a, and miR-92a) [<xref rid="B97-ijms-17-00093" ref-type="bibr">97</xref>]. Recently, our group has reported that the miR-17-92 cluster increases tumour neovascularization by decreasing TSP-1 expression [<xref rid="B98-ijms-17-00093" ref-type="bibr">98</xref>]. Therefore, and due to the miRNA mechanism action, a decrease in miR-17-5p levels involve post-transcriptional upregulation of TSP-1 levels. This mechanism may reduce the angiogenic activity in the ovarian endometrioma; therefore, it could explain the low ability in the extracellular matrix invasion of this tissue observed in these ectopic lesions where frequently the ovarian tissue remains preserved.</p><fig id="ijms-17-00093-f003" position="float"><label>Figure 3</label><caption><p>Main systems affected in endometriosis and the references for the most relevant studies about the role of miRNAs regulating them in this disease in square brackets. Red lines represent new blood vessels in formation and red dots cells nuclei.</p></caption><graphic xlink:href="ijms-17-00093-g003"/></fig></sec><sec id="sec11-ijms-17-00093"><title>11. Circulating miRNAs as Biomarkers of Endometriosis</title><p>The study of circulating miRNAs as biomarkers of endometriosis is an emerging field of research, and to date only few studies have been published both in serum [<xref rid="B82-ijms-17-00093" ref-type="bibr">82</xref>] and plasma [<xref rid="B81-ijms-17-00093" ref-type="bibr">81</xref>,<xref rid="B83-ijms-17-00093" ref-type="bibr">83</xref>].</p><p>Wang <italic>et al.</italic> [<xref rid="B99-ijms-17-00093" ref-type="bibr">99</xref>] first performed a circulating miRNA array profiling in two pools of sera from 10 patients with endometriosis and 10 control women. After validation of results from array by qRT-PCR in sera from 60 patients and 25 control women, the authors found that miR-199a and miR-122 levels were upregulated and miR-145 *, miR-141 *, miR-542-3p, and miR-9 * downregulated in samples from patients in comparison to control women and could therefore serve as biomarkers of the disease.</p><p>Shortly after, another study in plasma was conducted by Jia <italic>et al.</italic> [<xref rid="B81-ijms-17-00093" ref-type="bibr">81</xref>]. 23 women with histologically proven endometriosis and 23 endometriosis-free controls were enrolled in the study and a miRNA microarray profiling was performed. Three out of the six miRNAs selected for validation by qRT-PCR (miR-17-5p, miR-20a, and miR-22) were proven to be significantly downregulated in patients and useful to discriminate women with endometriosis from patients.</p><p>In 2015, two studies have been published, extending the evidence of miRNAs as putative biomarkers of endometriosis in non-invasive biofluids. In the first case, levels of previously endometriosis-associated miRNAs, miR-135a,b and let-7a-f, were quantified in sera of 24 endometriosis patients and 24 control women. By means of a logistic regression approach, researchers found that combining levels of let-7b, let-7d, and let-7f in the proliferative phase obtained the highest area under the curve value in order to discriminate patients with endometriosis from control women. [<xref rid="B82-ijms-17-00093" ref-type="bibr">82</xref>]. Of note, several miRNAs were found to be differently expressed depending on the phase of the menstrual cycle in patients but not in controls, in agreement with previous reports [<xref rid="B100-ijms-17-00093" ref-type="bibr">100</xref>]. Finally, Rekker <italic>et al</italic> [<xref rid="B83-ijms-17-00093" ref-type="bibr">83</xref>] performed the last published study regarding circulating miRNAs as biomarkers of endometriosis. Based on previous literature, authors selected three miRNAs from the miR-200 family (miR-200a-3p, miR-200b-3p, and miR-141-3p) whose expression was assessed in plasma samples from 61 patients and 65 control women. The expression of all three miRNAs was downregulated in patients and miR-200a-3p and miR-141-3p showed the highest potential as noninvasive biomarkers for this benign condition. Remarkably, authors also analyzed variations of the levels of the three miRNAs of interest with time of sampling (morning/evening) finding lower levels in evening samples, perhaps due to circadian fluctuations in their expression. This is an interesting approach and points to the time of sampling as an important factor to be taken into account when performing circulating miRNAs studies.</p></sec><sec id="sec12-ijms-17-00093"><title>12. Conclusions</title><p>Among the epigenetic players, miRNAs have emerged as pivotal post-transcriptional regulators. To do this, these small non-coding RNAs bind to their target mRNAs and inhibit the translation process. The involvement of miRNAs in different pathological conditions has been well established and the miRNA expression profiles have been performed in biopsies from different diseases, including gynecological pathologies as endometriosis. Despite being a benign gynecological pathology, endometriosis deeply impairs the quality of life of affected women in terms of pain and infertility. Nowadays, the gold standard to diagnose endometriosis is laparoscopy. For this reason, several groups including ours are focused on characterizing a non-invasive or semi-invasive biomarker for the diagnosis of endometriosis at initial stages that overcomes the need for the current laparoscopy. Recently, circulating miRNAs have emerged as attractive molecules to be considered as biomarkers [<xref rid="B45-ijms-17-00093" ref-type="bibr">45</xref>], although deeper studies are required in order to characterize and validate a miRNA-based diagnostic tool. It is important to highlight the important differences in experimental design and preanalytical protocols among different studies evaluating the same pathology; making it difficult to compare results [<xref rid="B40-ijms-17-00093" ref-type="bibr">40</xref>]. For all these reasons, the World Endometriosis Research Foundation (WERF) has published recommendations in order to standardize the data and sample collection, processing and storage [<xref rid="B101-ijms-17-00093" ref-type="bibr">101</xref>,<xref rid="B102-ijms-17-00093" ref-type="bibr">102</xref>,<xref rid="B103-ijms-17-00093" ref-type="bibr">103</xref>,<xref rid="B104-ijms-17-00093" ref-type="bibr">104</xref>] and reduce the heterogeneity and improve the reproducibility between studies as summarize the <xref ref-type="fig" rid="ijms-17-00093-f004">Figure 4</xref>. It is essential to unify every step in endometriosis research. The first one is data collection; for this purpose the WERF have elaborated a guide for surgical data collection as well as video/photo of symptom documentation [<xref rid="B101-ijms-17-00093" ref-type="bibr">101</xref>,<xref rid="B102-ijms-17-00093" ref-type="bibr">102</xref>]. Regarding the study of biofluids, the WERF has defined the protocol in order to standardize the biospecimen collection, processing, and storage [<xref rid="B103-ijms-17-00093" ref-type="bibr">103</xref>]. Finally, the collection and storage of tissue samples have also been standardized according to the consensus document [<xref rid="B104-ijms-17-00093" ref-type="bibr">104</xref>]. All these documents [<xref rid="B101-ijms-17-00093" ref-type="bibr">101</xref>,<xref rid="B102-ijms-17-00093" ref-type="bibr">102</xref>,<xref rid="B103-ijms-17-00093" ref-type="bibr">103</xref>,<xref rid="B104-ijms-17-00093" ref-type="bibr">104</xref>] allow for unifying the studies performed around the world about endometriosis. The aforementioned guides could be also useful for the study and validation in other diseases; these steps avoid the publication of dissimilar studies performed in the &#x0201c;same&#x0201d; disease but employing different protocols. This could be a simple way to obtain robust conclusions and be able to standardize new biomarkers. However, the study of miRNAs as biomarkers implies additional considerations. As it has been previously described, miRNAs are very stable circulating molecules; however heterogeneity among patients seems to be substantial. This feature is even more evident when results from one study are replicated by other group. Based on our own experience, pharmacological treatments, clinical conditions, or even diet can affect severely miRNA expression profiles in plasma.</p><fig id="ijms-17-00093-f004" position="float"><label>Figure 4</label><caption><p>Preanalytical considerations for the miRNA study and relevant literature in square brackets in order to obtain robust conclusions in the standardization of new biomarkers in endometriosis.</p></caption><graphic xlink:href="ijms-17-00093-g004"/></fig><p>In conclusion, miRNAs have emerged as new biomarkers valid for diagnostics or prognostics of several diseases. However, standardization in sample and clinical data collection; sample processing and storage; and technical protocols become essential for saving time and money in the assessment of miRNAs as biomarkers.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by FSE, ISCIII and FEDER (PI14/01309 and FI12/00012), RIC (RD12/0042/0029), Aitana Braza-Bo&#x000ef;ls is a &#x0201c;Sara Borrell&#x0201d; researcher (CD13/0005) and Juan Sandoval is a &#x0201c;Miguel Servet&#x0201d; researcher (CP13/00055), and IIS La Fe (2011-211).</p></ack><notes><title>Author Contributions</title><p>Josep Mar&#x000ed;-Alexandre and Dolors S&#x000e1;nchez-Izquierdo have revised the literature, draft the manuscript and prepare some figures. Juan Gilabert-Estell&#x000e9;s has written the manuscript. Mois&#x000e9;s Barcel&#x000f3;-Molina has elaborated some figures and revised the manuscript. Aitana Braza-Bo&#x000ef;ls and Juan Sandoval conceived and designed the review, written and revised the manuscript. </p></notes><notes><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-17-00093"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crick</surname><given-names>F.</given-names></name></person-group>
<article-title>Central dogma of molecular biology</article-title>
<source>Nature</source>
<year>1970</year>
<volume>227</volume>
<fpage>561</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1038/227561a0</pub-id>
<?supplied-pmid 4913914?><pub-id pub-id-type="pmid">4913914</pub-id></element-citation></ref><ref id="B2-ijms-17-00093"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holley</surname><given-names>R.W.</given-names></name><name><surname>Apgar</surname><given-names>J.</given-names></name><name><surname>Everett</surname><given-names>G.A.</given-names></name><name><surname>Madison</surname><given-names>J.T.</given-names></name><name><surname>Marquisee</surname><given-names>M.</given-names></name><name><surname>Merrill</surname><given-names>S.H.</given-names></name><name><surname>Penswick</surname><given-names>J.R.</given-names></name><name><surname>Zamir</surname><given-names>A.</given-names></name></person-group>
<article-title>Structure of a ribonucleic acid</article-title>
<source>Science</source>
<year>1965</year>
<volume>147</volume>
<fpage>1462</fpage>
<lpage>1465</lpage>
<pub-id pub-id-type="doi">10.1126/science.147.3664.1462</pub-id>
<?supplied-pmid 14263761?><pub-id pub-id-type="pmid">14263761</pub-id></element-citation></ref><ref id="B3-ijms-17-00093"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Bakel</surname><given-names>H.</given-names></name><name><surname>Nislow</surname><given-names>C.</given-names></name><name><surname>Blencowe</surname><given-names>B.J.</given-names></name><name><surname>Hughes</surname><given-names>T.R.</given-names></name></person-group>
<article-title>Most &#x0201c;dark matter&#x0201d; transcripts are associated with known genes</article-title>
<source>PLoS Biol.</source>
<year>2010</year>
<volume>18</volume>
<elocation-id>93</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000371</pub-id>
<?supplied-pmid 20502517?><pub-id pub-id-type="pmid">20502517</pub-id></element-citation></ref><ref id="B4-ijms-17-00093"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phillips</surname><given-names>T.</given-names></name></person-group>
<article-title>Small non-coding RNA and gene expression</article-title>
<source>Nat. Educ.</source>
<year>2008</year>
<volume>1</volume>
<fpage>115</fpage>
</element-citation></ref><ref id="B5-ijms-17-00093"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>T.</given-names></name><name><surname>Batze</surname><given-names>P.</given-names></name><name><surname>Berezikov</surname><given-names>E.</given-names></name><name><surname>Eilbeck</surname><given-names>K.</given-names></name><name><surname>Eppig</surname><given-names>J.T.</given-names></name><name><surname>McAndrews</surname><given-names>M.S.</given-names></name><name><surname>Singer</surname><given-names>A.</given-names></name><name><surname>Postlethwait</surname><given-names>J.H.</given-names></name></person-group>
<article-title>miRNA Nomenclature: A View Incorporating Genetic Origins, Biosynthetic Pathways, and Sequence Variants</article-title>
<source>Trends Genet.</source>
<year>2015</year>
<volume>31</volume>
<fpage>613</fpage>
<lpage>626</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2015.09.002</pub-id>
<?supplied-pmid 26453491?><pub-id pub-id-type="pmid">26453491</pub-id></element-citation></ref><ref id="B6-ijms-17-00093"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><collab>The ENCODE Project Consortium</collab></person-group>
<article-title>Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project</article-title>
<source>Nature</source>
<year>2007</year>
<volume>447</volume>
<fpage>799</fpage>
<lpage>816</lpage>
<pub-id pub-id-type="pmid">17571346</pub-id></element-citation></ref><ref id="B7-ijms-17-00093"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><collab>The ENCODE Project Consortium</collab></person-group>
<article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
<source>Nature</source>
<year>2012</year>
<volume>489</volume>
<fpage>57</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">22955616</pub-id></element-citation></ref><ref id="B8-ijms-17-00093"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nardone</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>D.U.</given-names></name><name><surname>Ansel</surname><given-names>K.M.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name></person-group>
<article-title>Bioinformatics for the &#x0201c;bench biologist&#x0201d;: How to find regulatory regions in genomic DNA</article-title>
<source>Nat. Immunol.</source>
<year>2004</year>
<volume>5</volume>
<fpage>768</fpage>
<lpage>774</lpage>
<pub-id pub-id-type="doi">10.1038/ni0804-768</pub-id>
<?supplied-pmid 15282556?><pub-id pub-id-type="pmid">15282556</pub-id></element-citation></ref><ref id="B9-ijms-17-00093"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>C.C.</given-names></name><name><surname>Ramirez-Carrozzi</surname><given-names>V.R.</given-names></name><name><surname>Smale</surname><given-names>S.T.</given-names></name></person-group>
<article-title>Pursuing gene regulation &#x0201c;logic&#x0201d; via RNA interference and chromatin immunoprecipitation</article-title>
<source>Nat. Immunol.</source>
<year>2006</year>
<volume>7</volume>
<fpage>692</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="doi">10.1038/ni0706-692</pub-id>
<?supplied-pmid 16785883?><pub-id pub-id-type="pmid">16785883</pub-id></element-citation></ref><ref id="B10-ijms-17-00093"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ozsolak</surname><given-names>F.</given-names></name><name><surname>Poling</surname><given-names>L.L.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.S.</given-names></name><name><surname>Roeder</surname><given-names>R.G.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>J.S.</given-names></name><name><surname>Fisher</surname><given-names>D.E.</given-names></name></person-group>
<article-title>Chromatin structure analyses identify miRNA promoters</article-title>
<source>Genes Dev.</source>
<year>2008</year>
<volume>15</volume>
<fpage>3172</fpage>
<lpage>3183</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1706508</pub-id>
<?supplied-pmid 19056895?><pub-id pub-id-type="pmid">19056895</pub-id></element-citation></ref><ref id="B11-ijms-17-00093"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Visel</surname><given-names>A.</given-names></name><name><surname>Rubin</surname><given-names>E.M.</given-names></name><name><surname>Pennacchio</surname><given-names>L.A.</given-names></name></person-group>
<article-title>Genomic views of distant-acting enhancers</article-title>
<source>Nature</source>
<year>2009</year>
<volume>10</volume>
<fpage>199</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1038/nature08451</pub-id>
<?supplied-pmid 19741700?><pub-id pub-id-type="pmid">19741700</pub-id></element-citation></ref><ref id="B12-ijms-17-00093"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noonan</surname><given-names>J.P.</given-names></name><name><surname>McCallion</surname><given-names>A.S.</given-names></name></person-group>
<article-title>Genomics of long-range regulatory elements</article-title>
<source>Annu. Rev. Genom. Hum. Genet.</source>
<year>2010</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-genom-082509-141651</pub-id>
<?supplied-pmid 20438361?><pub-id pub-id-type="pmid">20438361</pub-id></element-citation></ref><ref id="B13-ijms-17-00093"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Christov</surname><given-names>C.P.</given-names></name><name><surname>Gardiner</surname><given-names>T.J.</given-names></name><name><surname>Sz&#x000fc;ts</surname><given-names>D.</given-names></name><name><surname>Krude</surname><given-names>T.</given-names></name></person-group>
<article-title>Functional requirement of noncoding Y RNAs for human chromosomal DNA replication</article-title>
<source>Mol. Cell. Biol.</source>
<year>2006</year>
<volume>26</volume>
<fpage>6993</fpage>
<lpage>7004</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.01060-06</pub-id>
<?supplied-pmid 16943439?><pub-id pub-id-type="pmid">16943439</pub-id></element-citation></ref><ref id="B14-ijms-17-00093"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>A.T.</given-names></name><name><surname>Langley</surname><given-names>A.R.</given-names></name><name><surname>Christov</surname><given-names>C.P.</given-names></name><name><surname>Kheir</surname><given-names>E.</given-names></name><name><surname>Shafee</surname><given-names>T.</given-names></name><name><surname>Gardiner</surname><given-names>T.J.</given-names></name><name><surname>Krude</surname><given-names>T.</given-names></name></person-group>
<article-title>Dynamic interaction of Y RNAs with chromatin and initiation proteins during human DNA replication</article-title>
<source>J. Cell Sci.</source>
<year>2011</year>
<volume>15</volume>
<fpage>2058</fpage>
<lpage>2069</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.086561</pub-id>
<?supplied-pmid 21610089?><pub-id pub-id-type="pmid">21610089</pub-id></element-citation></ref><ref id="B15-ijms-17-00093"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roberts</surname><given-names>T.C.</given-names></name></person-group>
<article-title>The MicroRNA biology of the mammalian nucleus</article-title>
<source>Mol. Ther. Nucleic Acids</source>
<year>2014</year>
<volume>19</volume>
<fpage>e188</fpage>
<pub-id pub-id-type="doi">10.1038/mtna.2014.40</pub-id>
<?supplied-pmid 25137140?><pub-id pub-id-type="pmid">25137140</pub-id></element-citation></ref><ref id="B16-ijms-17-00093"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>R.C.</given-names></name><name><surname>Feinbaum</surname><given-names>R.L.</given-names></name><name><surname>Ambros</surname><given-names>V.</given-names></name></person-group>
<article-title>The C. elegans heterochronic gene <italic>lin-4</italic> encodes small RNAs with antisense complementarity to <italic>lin-14</italic></article-title>
<source>Cell</source>
<year>1993</year>
<volume>3</volume>
<fpage>843</fpage>
<lpage>854</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(93)90529-Y</pub-id>
<pub-id pub-id-type="pmid">8252621</pub-id></element-citation></ref><ref id="B17-ijms-17-00093"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>MicroRNAs: Genomics, biogenesis, mechanism, and function</article-title>
<source>Cell</source>
<year>2004</year>
<volume>116</volume>
<fpage>281</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(04)00045-5</pub-id>
<pub-id pub-id-type="pmid">14744438</pub-id></element-citation></ref><ref id="B18-ijms-17-00093"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eulalio</surname><given-names>A.</given-names></name><name><surname>Huntzinger</surname><given-names>E.</given-names></name><name><surname>Izaurralde</surname><given-names>E.</given-names></name></person-group>
<article-title>Getting to the root of miRNA-mediated gene silencing</article-title>
<source>Cell</source>
<year>2008</year>
<volume>132</volume>
<fpage>9</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.12.024</pub-id>
<?supplied-pmid 18191211?><pub-id pub-id-type="pmid">18191211</pub-id></element-citation></ref><ref id="B19-ijms-17-00093"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>MicroRNAs: Target recognition and regulatory functions</article-title>
<source>Cell</source>
<year>2009</year>
<volume>23</volume>
<fpage>215</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id>
<?supplied-pmid 19167326?><pub-id pub-id-type="pmid">19167326</pub-id></element-citation></ref><ref id="B20-ijms-17-00093"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ambros</surname><given-names>V.</given-names></name><name><surname>Bartel</surname><given-names>B.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name><name><surname>Burge</surname><given-names>C.B.</given-names></name><name><surname>Carrington</surname><given-names>J.C.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Dreyfuss</surname><given-names>G.</given-names></name><name><surname>Eddy</surname><given-names>S.R.</given-names></name><name><surname>Griffiths-Jones</surname><given-names>S.</given-names></name><name><surname>Marshall</surname><given-names>M.</given-names></name><etal/></person-group>
<article-title>A uniform system for microRNA annotation</article-title>
<source>RNA</source>
<year>2003</year>
<volume>9</volume>
<fpage>277</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="doi">10.1261/rna.2183803</pub-id>
<?supplied-pmid 12592000?><pub-id pub-id-type="pmid">12592000</pub-id></element-citation></ref><ref id="B21-ijms-17-00093"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burney</surname><given-names>R.O.</given-names></name><name><surname>Hamilton</surname><given-names>A.E.</given-names></name><name><surname>Aghajanova</surname><given-names>L.</given-names></name><name><surname>Vo</surname><given-names>K.C.</given-names></name><name><surname>Nezhat</surname><given-names>C.N.</given-names></name><name><surname>Lessey</surname><given-names>B.A.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name></person-group>
<article-title>MicroRNA expression profiling of eutopic secretory endometrium in women with <italic>versus</italic> without endometriosis</article-title>
<source>Mol. Hum. Reprod.</source>
<year>2009</year>
<volume>15</volume>
<fpage>625</fpage>
<lpage>631</lpage>
<pub-id pub-id-type="doi">10.1093/molehr/gap068</pub-id>
<?supplied-pmid 19692421?><pub-id pub-id-type="pmid">19692421</pub-id></element-citation></ref><ref id="B22-ijms-17-00093"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohlsson-Teague</surname><given-names>E.M.</given-names></name><name><surname>van der Hoek</surname><given-names>K.H.</given-names></name><name><surname>van der Hoek</surname><given-names>M.B.</given-names></name><name><surname>Perry</surname><given-names>N.</given-names></name><name><surname>Wagaarachchi</surname><given-names>P.</given-names></name><name><surname>Robertson</surname><given-names>S.A.</given-names></name><name><surname>Print</surname><given-names>C.G.</given-names></name><name><surname>Hull</surname><given-names>L.M.</given-names></name></person-group>
<article-title>MicroRNA-regulated pathways associated with endometriosis</article-title>
<source>Mol. Endocrinol.</source>
<year>2009</year>
<volume>23</volume>
<fpage>265</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1210/me.2008-0387</pub-id>
<?supplied-pmid 19074548?><pub-id pub-id-type="pmid">19074548</pub-id></element-citation></ref><ref id="B23-ijms-17-00093"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuokkanen</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Ojalvo</surname><given-names>L.</given-names></name><name><surname>Benard</surname><given-names>L.</given-names></name><name><surname>Santoro</surname><given-names>N.</given-names></name><name><surname>Pollard</surname><given-names>J.W.</given-names></name></person-group>
<article-title>Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium</article-title>
<source>Biol. Reprod.</source>
<year>2010</year>
<volume>82</volume>
<fpage>791</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="doi">10.1095/biolreprod.109.081059</pub-id>
<?supplied-pmid 19864316?><pub-id pub-id-type="pmid">19864316</pub-id></element-citation></ref><ref id="B24-ijms-17-00093"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohlsson&#x02013;Teague</surname><given-names>E.M.</given-names></name><name><surname>Print</surname><given-names>C.G.</given-names></name><name><surname>Hull</surname><given-names>M.L.</given-names></name></person-group>
<article-title>The role of microRNAs in endometriosis and associated reproductive conditions</article-title>
<source>Hum. Reprod. Update</source>
<year>2010</year>
<volume>16</volume>
<fpage>142</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1093/humupd/dmp034</pub-id>
<?supplied-pmid 19773286?><pub-id pub-id-type="pmid">19773286</pub-id></element-citation></ref><ref id="B25-ijms-17-00093"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilabert-Estelles</surname><given-names>J.</given-names></name><name><surname>Braza-Boils</surname><given-names>A.</given-names></name><name><surname>Ramon</surname><given-names>L.A.</given-names></name><name><surname>Zorio</surname><given-names>E.</given-names></name><name><surname>Medina</surname><given-names>P.</given-names></name><name><surname>Espa&#x000f1;a</surname><given-names>F.</given-names></name><name><surname>Estell&#x000e9;s</surname><given-names>A.</given-names></name></person-group>
<article-title>Role of microRNAs in gynecological pathology</article-title>
<source>Curr. Med. Chem.</source>
<year>2012</year>
<volume>19</volume>
<fpage>2406</fpage>
<lpage>2413</lpage>
<pub-id pub-id-type="doi">10.2174/092986712800269362</pub-id>
<?supplied-pmid 22455593?><pub-id pub-id-type="pmid">22455593</pub-id></element-citation></ref><ref id="B26-ijms-17-00093"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ram&#x000f3;n</surname><given-names>L.A.</given-names></name><name><surname>Braza-Bo&#x000ef;ls</surname><given-names>A.</given-names></name><name><surname>Gilabert</surname><given-names>J.</given-names></name><name><surname>Chirivella</surname><given-names>M.</given-names></name><name><surname>Espa&#x000f1;a</surname><given-names>F.</given-names></name><name><surname>Estell&#x000e9;s</surname><given-names>A.</given-names></name><name><surname>Gilabert-Estell&#x000e9;s</surname><given-names>J.</given-names></name></person-group>
<article-title>microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer</article-title>
<source>Hum. Reprod.</source>
<year>2012</year>
<volume>27</volume>
<fpage>3036</fpage>
<lpage>3045</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/des292</pub-id>
<?supplied-pmid 22904162?><pub-id pub-id-type="pmid">22904162</pub-id></element-citation></ref><ref id="B27-ijms-17-00093"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braza-Bo&#x000ef;ls</surname><given-names>A.</given-names></name><name><surname>Mar&#x000ed;-Alexandre</surname><given-names>J.</given-names></name><name><surname>Gilabert</surname><given-names>J.</given-names></name><name><surname>S&#x000e1;nchez-Izquierdo</surname><given-names>D.</given-names></name><name><surname>Espa&#x000f1;a</surname><given-names>F.</given-names></name><name><surname>Estell&#x000e9;s</surname><given-names>A.</given-names></name><name><surname>Gilabert-Estell&#x000e9;s</surname><given-names>J.</given-names></name></person-group>
<article-title>MicroRNA expression profile in endometriosis: Its relation to angiogenesis and fibrinolytic factors</article-title>
<source>Hum. Reprod.</source>
<year>2014</year>
<volume>29</volume>
<fpage>978</fpage>
<lpage>988</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/deu019</pub-id>
<?supplied-pmid 24608518?><pub-id pub-id-type="pmid">24608518</pub-id></element-citation></ref><ref id="B28-ijms-17-00093"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mar&#x000ed;-Alexandre</surname><given-names>J.</given-names></name><name><surname>Garc&#x000ed;a-Oms</surname><given-names>J.</given-names></name><name><surname>Barcel&#x000f3;-Molina</surname><given-names>M.</given-names></name><name><surname>Gilabert-Aguilar</surname><given-names>J.</given-names></name><name><surname>Estell&#x000e9;s</surname><given-names>A.</given-names></name><name><surname>Braza-Bo&#x000ef;ls</surname><given-names>A.</given-names></name><name><surname>Gilabert-Estell&#x000e9;s</surname><given-names>J.</given-names></name></person-group>
<article-title>MicroRNAs and angiogenesis in endometriosis</article-title>
<source>Thromb. Res.</source>
<year>2015</year>
<volume>135</volume>
<fpage>S38</fpage>
<lpage>S40</lpage>
<pub-id pub-id-type="doi">10.1016/S0049-3848(15)50439-8</pub-id>
<pub-id pub-id-type="pmid">25903532</pub-id></element-citation></ref><ref id="B29-ijms-17-00093"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lund</surname><given-names>E.</given-names></name><name><surname>G&#x000fc;ttinger</surname><given-names>S.</given-names></name><name><surname>Calado</surname><given-names>A.</given-names></name><name><surname>Dahlberg</surname><given-names>J.E.</given-names></name><name><surname>Kutay</surname><given-names>U.</given-names></name></person-group>
<article-title>Nuclear export of MicroRNA precursors</article-title>
<source>Science</source>
<year>2004</year>
<volume>303</volume>
<fpage>95</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1126/science.1090599</pub-id>
<?supplied-pmid 14631048?><pub-id pub-id-type="pmid">14631048</pub-id></element-citation></ref><ref id="B30-ijms-17-00093"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meijer</surname><given-names>H.A.</given-names></name><name><surname>Smith</surname><given-names>E.M.</given-names></name><name><surname>Bushell</surname><given-names>M.</given-names></name></person-group>
<article-title>Regulation of miRNA strand selection: Follow the leader?</article-title>
<source>Biochem. Soc. Trans.</source>
<year>2014</year>
<volume>42</volume>
<fpage>1135</fpage>
<lpage>1140</lpage>
<pub-id pub-id-type="doi">10.1042/BST20140142</pub-id>
<?supplied-pmid 25110015?><pub-id pub-id-type="pmid">25110015</pub-id></element-citation></ref><ref id="B31-ijms-17-00093"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Machlin</surname><given-names>E.S.</given-names></name><name><surname>Sarnow</surname><given-names>P.</given-names></name><name><surname>Sagan</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Masking the 5&#x02019; terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2011</year>
<volume>22</volume>
<fpage>3193</fpage>
<lpage>3198</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1012464108</pub-id>
<?supplied-pmid 21220300?><pub-id pub-id-type="pmid">21220300</pub-id></element-citation></ref><ref id="B32-ijms-17-00093"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neilsen</surname><given-names>C.T.</given-names></name><name><surname>Goodall</surname><given-names>G.J.</given-names></name><name><surname>Bracken</surname><given-names>C.P.</given-names></name></person-group>
<article-title>IsomiRs: The overlooked repertoire in the dynamic microRNAome</article-title>
<source>Trends Genet.</source>
<year>2012</year>
<volume>28</volume>
<fpage>544</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2012.07.005</pub-id>
<?supplied-pmid 22883467?><pub-id pub-id-type="pmid">22883467</pub-id></element-citation></ref><ref id="B33-ijms-17-00093"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Westholm</surname><given-names>J.O.</given-names></name><name><surname>Lai</surname><given-names>E.C.</given-names></name></person-group>
<article-title>Mirtrons: MicroRNA biogenesis via splicing</article-title>
<source>Biochimie</source>
<year>2011</year>
<volume>93</volume>
<fpage>1897</fpage>
<lpage>1904</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2011.06.017</pub-id>
<?supplied-pmid 21712066?><pub-id pub-id-type="pmid">21712066</pub-id></element-citation></ref><ref id="B34-ijms-17-00093"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>A.</given-names></name><name><surname>Griffiths-Jones</surname><given-names>S.</given-names></name><name><surname>Ashurst</surname><given-names>J.L.</given-names></name><name><surname>Bradley</surname><given-names>A.</given-names></name></person-group>
<article-title>Identification of mammalian microRNA host genes and transcription units</article-title>
<source>Genome Res.</source>
<year>2004</year>
<volume>14</volume>
<fpage>1902</fpage>
<lpage>1910</lpage>
<pub-id pub-id-type="doi">10.1101/gr.2722704</pub-id>
<?supplied-pmid 15364901?><pub-id pub-id-type="pmid">15364901</pub-id></element-citation></ref><ref id="B35-ijms-17-00093"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baskerville</surname><given-names>S.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group>
<article-title>Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes</article-title>
<source>RNA</source>
<year>2005</year>
<volume>11</volume>
<fpage>241</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1261/rna.7240905</pub-id>
<?supplied-pmid 15701730?><pub-id pub-id-type="pmid">15701730</pub-id></element-citation></ref><ref id="B36-ijms-17-00093"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gregory</surname><given-names>R.I.</given-names></name><name><surname>Shiekhattar</surname><given-names>R.</given-names></name></person-group>
<article-title>MicroRNA Biogenesis and Cancer</article-title>
<source>Cancer Res.</source>
<year>2005</year>
<volume>65</volume>
<fpage>3509</fpage>
<lpage>3512</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-0298</pub-id>
<?supplied-pmid 15867338?><pub-id pub-id-type="pmid">15867338</pub-id></element-citation></ref><ref id="B37-ijms-17-00093"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kozomara</surname><given-names>A.</given-names></name><name><surname>Griffiths-Jones</surname><given-names>S.</given-names></name></person-group>
<article-title>miRBase: Annotating high confidence microRNAs using deep sequencing data. A uniform system for microRNA annotation</article-title>
<source>Nucleic Acids Res.</source>
<year>2014</year>
<volume>42</volume>
<fpage>68</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt1181</pub-id>
<?supplied-pmid 24275495?><pub-id pub-id-type="pmid">24275495</pub-id></element-citation></ref><ref id="B38-ijms-17-00093"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hacia</surname><given-names>J.G.</given-names></name><name><surname>Fan</surname><given-names>J.B.</given-names></name><name><surname>Ryder</surname><given-names>O.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Edgemon</surname><given-names>K.</given-names></name><name><surname>Ghandour</surname><given-names>G.</given-names></name><name><surname>Mayer</surname><given-names>R.A.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Hsie</surname><given-names>L.</given-names></name><name><surname>Robbins</surname><given-names>C.M.</given-names></name><etal/></person-group>
<article-title>Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays</article-title>
<source>Nat. Genet.</source>
<year>1999</year>
<volume>22</volume>
<fpage>164</fpage>
<lpage>167</lpage>
<?supplied-pmid 10369258?><pub-id pub-id-type="pmid">10369258</pub-id></element-citation></ref><ref id="B39-ijms-17-00093"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zampetaki</surname><given-names>A.</given-names></name><name><surname>Mayr</surname><given-names>M.</given-names></name></person-group>
<article-title>Analytical challenges and technical limitations in assessing circulating miRNAs</article-title>
<source>Thromb. Haemost.</source>
<year>2012</year>
<volume>108</volume>
<fpage>592</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="doi">10.1160/TH12-02-0097</pub-id>
<?supplied-pmid 22627831?><pub-id pub-id-type="pmid">22627831</pub-id></element-citation></ref><ref id="B40-ijms-17-00093"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Urbanek</surname><given-names>M.O.</given-names></name><name><surname>Nawrocka</surname><given-names>A.U.</given-names></name><name><surname>Krzyzosiak</surname><given-names>W.J.</given-names></name></person-group>
<article-title>Small RNA Detection by in Situ Hybridization Methods</article-title>
<source>Int. J. Mol. Sci.</source>
<year>2015</year>
<volume>16</volume>
<fpage>13259</fpage>
<lpage>13286</lpage>
<pub-id pub-id-type="doi">10.3390/ijms160613259</pub-id>
<?supplied-pmid 26068454?><pub-id pub-id-type="pmid">26068454</pub-id></element-citation></ref><ref id="B41-ijms-17-00093"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franciscus</surname><given-names>A.</given-names></name></person-group>
<article-title>A Brief History of Hepatitis C</article-title>
<source>Hepat. C Support Proj. Fact Sheet</source>
<year>2015</year>
<volume>12</volume>
<fpage>1</fpage>
<lpage>8</lpage>
</element-citation></ref><ref id="B42-ijms-17-00093"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><collab>Biomarkers Definitions Working Group</collab></person-group>
<article-title>Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework</article-title>
<source>Clin. Pharmacol. Ther.</source>
<year>2001</year>
<volume>69</volume>
<fpage>89</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">11240971</pub-id></element-citation></ref><ref id="B43-ijms-17-00093"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mayr</surname><given-names>M.</given-names></name><name><surname>Zampetaki</surname><given-names>A.</given-names></name><name><surname>Willeit</surname><given-names>P.</given-names></name><name><surname>Willeit</surname><given-names>J.</given-names></name><name><surname>Kiechl</surname><given-names>S.</given-names></name></person-group>
<article-title>MicroRNAs within the continuum of postgenomics biomarker discovery</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2013</year>
<volume>33</volume>
<fpage>206</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.112.300141</pub-id>
<?supplied-pmid 23325478?><pub-id pub-id-type="pmid">23325478</pub-id></element-citation></ref><ref id="B44-ijms-17-00093"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zorio</surname><given-names>E.</given-names></name><name><surname>Medina</surname><given-names>P.</given-names></name><name><surname>Rueda</surname><given-names>J.</given-names></name><name><surname>Mill&#x000e1;n</surname><given-names>J.M.</given-names></name><name><surname>Arnau</surname><given-names>M.A.</given-names></name><name><surname>Beneyto</surname><given-names>M.</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>F.</given-names></name><name><surname>Gimeno</surname><given-names>J.R.</given-names></name><name><surname>Osca</surname><given-names>J.</given-names></name><name><surname>Salvador</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Insights into the role of microRNAs in cardiac diseases: From biological signalling to therapeutic targets</article-title>
<source>Cardiovasc. Hematol. Agents Med. Chem.</source>
<year>2009</year>
<volume>7</volume>
<fpage>82</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.2174/187152509787047676</pub-id>
<?supplied-pmid 19149547?><pub-id pub-id-type="pmid">19149547</pub-id></element-citation></ref><ref id="B45-ijms-17-00093"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wittmann</surname><given-names>J.</given-names></name><name><surname>J&#x000e4;ck</surname><given-names>H.M.</given-names></name></person-group>
<article-title>Serum microRNAs as powerful cancer biomarkers</article-title>
<source>Biochim. Biophys. Acta</source>
<year>2010</year>
<volume>1806</volume>
<fpage>200</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbcan.2010.07.002</pub-id>
<?supplied-pmid 20637263?><pub-id pub-id-type="pmid">20637263</pub-id></element-citation></ref><ref id="B46-ijms-17-00093"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weber</surname><given-names>J.A.</given-names></name><name><surname>Baxter</surname><given-names>D.H.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>D.Y.</given-names></name><name><surname>Huang</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>M.J.</given-names></name><name><surname>Galas</surname><given-names>D.J.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name></person-group>
<article-title>The microRNA spectrum in 12 body fluids</article-title>
<source>Clin. Chem.</source>
<year>2010</year>
<volume>56</volume>
<fpage>1733</fpage>
<lpage>1741</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2010.147405</pub-id>
<?supplied-pmid 20847327?><pub-id pub-id-type="pmid">20847327</pub-id></element-citation></ref><ref id="B47-ijms-17-00093"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silva</surname><given-names>S.S.</given-names></name><name><surname>Lopes</surname><given-names>C.</given-names></name><name><surname>Teixeira</surname><given-names>A.L.</given-names></name><name><surname>Carneiro de Sousa</surname><given-names>M.J.</given-names></name><name><surname>Medeiros</surname><given-names>R.</given-names></name></person-group>
<article-title>Forensic miRNA: Potential biomarker for body fluids?</article-title>
<source>Forensic Sci. Int. Genet.</source>
<year>2015</year>
<volume>14</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.fsigen.2014.09.002</pub-id>
<?supplied-pmid 25280377?><pub-id pub-id-type="pmid">25280377</pub-id></element-citation></ref><ref id="B48-ijms-17-00093"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cortez</surname><given-names>M.A.</given-names></name><name><surname>Bueso-Ramos</surname><given-names>C.</given-names></name><name><surname>Ferdin</surname><given-names>J.</given-names></name><name><surname>Lopez-Berestein</surname><given-names>G.</given-names></name><name><surname>Sood</surname><given-names>A.K.</given-names></name><name><surname>Calin</surname><given-names>G.A.</given-names></name></person-group>
<article-title>MicroRNAs in body fluids: The mix of hormones and biomarkers</article-title>
<source>Nat. Rev. Clin. Oncol.</source>
<year>2011</year>
<volume>8</volume>
<fpage>467</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1038/nrclinonc.2011.76</pub-id>
<?supplied-pmid 21647195?><pub-id pub-id-type="pmid">21647195</pub-id></element-citation></ref><ref id="B49-ijms-17-00093"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shah</surname><given-names>M.Y.</given-names></name><name><surname>Calin</surname><given-names>G.A.</given-names></name></person-group>
<article-title>The Mix of Two Worlds: Non-Coding RNAs and Hormones</article-title>
<source>Nucleic Acid Ther.</source>
<year>2013</year>
<volume>23</volume>
<fpage>2</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1089/nat.2012.0375</pub-id>
<?supplied-pmid 23051203?><pub-id pub-id-type="pmid">23051203</pub-id></element-citation></ref><ref id="B50-ijms-17-00093"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valadi</surname><given-names>H.</given-names></name><name><surname>Ekstr&#x000f6;m</surname><given-names>K.</given-names></name><name><surname>Bossios</surname><given-names>A.</given-names></name><name><surname>Sj&#x000f6;strand</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>J.J.</given-names></name><name><surname>L&#x000f6;tvall</surname><given-names>J.O.</given-names></name></person-group>
<article-title>Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells</article-title>
<source>Nat. Cell Biol.</source>
<year>2007</year>
<volume>9</volume>
<fpage>654</fpage>
<lpage>659</lpage>
<pub-id pub-id-type="doi">10.1038/ncb1596</pub-id>
<?supplied-pmid 17486113?><pub-id pub-id-type="pmid">17486113</pub-id></element-citation></ref><ref id="B51-ijms-17-00093"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hunter</surname><given-names>M.P.</given-names></name><name><surname>Ismail</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Aguda</surname><given-names>B.D.</given-names></name><name><surname>Lee</surname><given-names>E.J.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>T.</given-names></name><name><surname>Schafer</surname><given-names>J.</given-names></name><name><surname>Ting Lee</surname><given-names>M.L.</given-names></name><name><surname>Schmittgen</surname><given-names>T.D.</given-names></name><etal/></person-group>
<article-title>Detection of microRNA Expression in Human Peripheral Blood Microvesicles</article-title>
<source>PLoS ONE</source>
<year>2008</year>
<volume>3</volume>
<elocation-id>93</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0003694</pub-id>
<?supplied-pmid 19002258?><pub-id pub-id-type="pmid">19002258</pub-id></element-citation></ref><ref id="B52-ijms-17-00093"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zernecke</surname><given-names>A.</given-names></name><name><surname>Bidzhekov</surname><given-names>K.</given-names></name><name><surname>Noels</surname><given-names>H.</given-names></name><name><surname>Shagdarsuren</surname><given-names>E.</given-names></name><name><surname>Gan</surname><given-names>L.</given-names></name><name><surname>Denecke</surname><given-names>B.</given-names></name><name><surname>Hristov</surname><given-names>M.</given-names></name><name><surname>K&#x000f6;ppel</surname><given-names>T.</given-names></name><name><surname>Jahantigh</surname><given-names>M.N.</given-names></name><name><surname>Lutgens</surname><given-names>E.</given-names></name><etal/></person-group>
<article-title>Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection</article-title>
<source>Sci. Signal.</source>
<year>2009</year>
<volume>8</volume>
<fpage>ra81</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.2000610</pub-id>
<?supplied-pmid 19996457?><pub-id pub-id-type="pmid">19996457</pub-id></element-citation></ref><ref id="B53-ijms-17-00093"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickers</surname><given-names>K.C.</given-names></name><name><surname>Palmisano</surname><given-names>B.T.</given-names></name><name><surname>Shoucri</surname><given-names>B.M.</given-names></name><name><surname>Shamburek</surname><given-names>R.D.</given-names></name><name><surname>Remaley</surname><given-names>A.T.</given-names></name></person-group>
<article-title>MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins</article-title>
<source>Nat. Cell Biol.</source>
<year>2011</year>
<volume>13</volume>
<fpage>423</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1038/ncb2210</pub-id>
<?supplied-pmid 21423178?><pub-id pub-id-type="pmid">21423178</pub-id></element-citation></ref><ref id="B54-ijms-17-00093"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arroyo</surname><given-names>J.D.</given-names></name><name><surname>Chevilleta</surname><given-names>J.R.</given-names></name><name><surname>Kroha</surname><given-names>E.M.</given-names></name><name><surname>Rufa</surname><given-names>I.K.</given-names></name><name><surname>Pritchardb</surname><given-names>C.C.</given-names></name><name><surname>Gibsonb</surname><given-names>D.F.</given-names></name><name><surname>Mitchella</surname><given-names>P.S.</given-names></name><name><surname>Bennetta</surname><given-names>C.F.</given-names></name><name><surname>Pogosova-Agadjanyand</surname><given-names>E.L.</given-names></name><name><surname>Stirewaltd</surname><given-names>D.L.</given-names></name><etal/></person-group>
<article-title>Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma</article-title>
<source>Prot. Nat. Acad. Sci.</source>
<year>2011</year>
<volume>108</volume>
<fpage>5003</fpage>
<lpage>5008</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1019055108</pub-id>
<?supplied-pmid 21383194?><pub-id pub-id-type="pmid">21383194</pub-id></element-citation></ref><ref id="B55-ijms-17-00093"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zampetaki</surname><given-names>A.</given-names></name><name><surname>Willeit</surname><given-names>P.</given-names></name><name><surname>Drozdov</surname><given-names>I.</given-names></name><name><surname>Kiechl</surname><given-names>S.</given-names></name><name><surname>Mayr</surname><given-names>M.</given-names></name></person-group>
<article-title>Profiling of circulating microRNAs: From single biomarkers to re-wired networks</article-title>
<source>Cardiovasc. Res.</source>
<year>2012</year>
<volume>3</volume>
<fpage>555</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1093/cvr/cvr266</pub-id>
<?supplied-pmid 22028337?><pub-id pub-id-type="pmid">22028337</pub-id></element-citation></ref><ref id="B56-ijms-17-00093"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kosaka</surname><given-names>N.</given-names></name><name><surname>Yoshioka</surname><given-names>Y.</given-names></name><name><surname>Hagiwara</surname><given-names>K.</given-names></name><name><surname>Tominaga</surname><given-names>N.</given-names></name><name><surname>Katsuda</surname><given-names>T.</given-names></name><name><surname>Ochiya</surname><given-names>T.</given-names></name></person-group>
<article-title>Trash or Treasure: extracellular microRNAs and cell-to-cell communication</article-title>
<source>Front. Genet.</source>
<year>2013</year>
<volume>4</volume>
<fpage>173</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2013.00173</pub-id>
<?supplied-pmid 24046777?><pub-id pub-id-type="pmid">24046777</pub-id></element-citation></ref><ref id="B57-ijms-17-00093"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turchinovich</surname><given-names>A.</given-names></name><name><surname>Samatov</surname><given-names>T.R.</given-names></name><name><surname>Tonevitsky</surname><given-names>A.G.</given-names></name><name><surname>Burwinkel</surname><given-names>B.</given-names></name></person-group>
<article-title>Circulating miRNAs: Cell-cell communication function?</article-title>
<source>Front. Genet.</source>
<year>2013</year>
<volume>4</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.3389/fgene.2013.00119</pub-id>
<?supplied-pmid 23825476?><pub-id pub-id-type="pmid">23825476</pub-id></element-citation></ref><ref id="B58-ijms-17-00093"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bang</surname><given-names>C.</given-names></name><name><surname>Batkai</surname><given-names>S.</given-names></name><name><surname>Dangwal</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>S.K.</given-names></name><name><surname>Foinquinos</surname><given-names>A.</given-names></name><name><surname>Holzmann</surname><given-names>A.</given-names></name><name><surname>Just</surname><given-names>A.</given-names></name><name><surname>Remke</surname><given-names>J.</given-names></name><name><surname>Zimmer</surname><given-names>K.</given-names></name><name><surname>Zeug</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy</article-title>
<source>J. Clin. Investig.</source>
<year>2014</year>
<volume>124</volume>
<fpage>2136</fpage>
<lpage>2146</lpage>
<pub-id pub-id-type="doi">10.1172/JCI70577</pub-id>
<?supplied-pmid 24743145?><pub-id pub-id-type="pmid">24743145</pub-id></element-citation></ref><ref id="B59-ijms-17-00093"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fabbri</surname><given-names>M.</given-names></name></person-group>
<article-title>TLRs as miRNA Receptors</article-title>
<source>Cancer Res.</source>
<year>2012</year>
<volume>72</volume>
<fpage>6333</fpage>
<lpage>6337</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-3229</pub-id>
<?supplied-pmid 23222301?><pub-id pub-id-type="pmid">23222301</pub-id></element-citation></ref><ref id="B60-ijms-17-00093"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fabbri</surname><given-names>M.</given-names></name><name><surname>Paone</surname><given-names>A.</given-names></name><name><surname>Calore</surname><given-names>F.</given-names></name><name><surname>Galli</surname><given-names>R.</given-names></name><name><surname>Gaudio</surname><given-names>E.</given-names></name><name><surname>Santhanam</surname><given-names>R.</given-names></name><name><surname>Lovat</surname><given-names>F.</given-names></name><name><surname>Fadda</surname><given-names>P.</given-names></name><name><surname>Mao</surname><given-names>C.</given-names></name><name><surname>Nuovo</surname><given-names>G.J.</given-names></name><etal/></person-group>
<article-title>MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2012</year>
<volume>109</volume>
<fpage>E2110</fpage>
<lpage>E2116</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1209414109</pub-id>
<?supplied-pmid 22753494?><pub-id pub-id-type="pmid">22753494</pub-id></element-citation></ref><ref id="B61-ijms-17-00093"><label>61.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>P.S.</given-names></name><name><surname>Parkin</surname><given-names>R.K.</given-names></name><name><surname>Kroh</surname><given-names>E.M.</given-names></name><name><surname>Fritz</surname><given-names>B.R.</given-names></name><name><surname>Wyman</surname><given-names>S.K.</given-names></name><name><surname>Pogosova-Agadjanyan</surname><given-names>E.L.</given-names></name><name><surname>Peterson</surname><given-names>A.</given-names></name><name><surname>Noteboom</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Briant</surname><given-names>K.C.</given-names></name><name><surname>Allen</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Circulating microRNAs as stable blood-based markers for cancer detection</article-title>
<source>Prot. Nat. Acad. Sci.</source>
<year>2008</year>
<volume>105</volume>
<fpage>10513</fpage>
<lpage>10518</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0804549105</pub-id>
<?supplied-pmid 18663219?><pub-id pub-id-type="pmid">18663219</pub-id></element-citation></ref><ref id="B62-ijms-17-00093"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>S.M.</given-names></name><name><surname>Creighton</surname><given-names>C.J.</given-names></name><name><surname>Han</surname><given-names>D.Y.</given-names></name><name><surname>Zariff</surname><given-names>A.</given-names></name><name><surname>Anderson</surname><given-names>M.L.</given-names></name><name><surname>Gunaratne</surname><given-names>P.H.</given-names></name><name><surname>Matzuk</surname><given-names>M.M.</given-names></name></person-group>
<article-title>Functional microRNA involved in endometriosis</article-title>
<source>Mol. Endocrinol.</source>
<year>2011</year>
<volume>25</volume>
<fpage>821</fpage>
<lpage>832</lpage>
<pub-id pub-id-type="doi">10.1210/me.2010-0371</pub-id>
<?supplied-pmid 21436257?><pub-id pub-id-type="pmid">21436257</pub-id></element-citation></ref><ref id="B63-ijms-17-00093"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nisolle</surname><given-names>M.</given-names></name><name><surname>Donnez</surname><given-names>J.</given-names></name></person-group>
<article-title>Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities</article-title>
<source>Fertil. Steril.</source>
<year>1997</year>
<volume>68</volume>
<fpage>585</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="doi">10.1016/S0015-0282(97)00191-X</pub-id>
<pub-id pub-id-type="pmid">9341595</pub-id></element-citation></ref><ref id="B64-ijms-17-00093"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giudice</surname><given-names>L.C.</given-names></name></person-group>
<article-title>Endometriosis</article-title>
<source>N. Engl. J. Med.</source>
<year>2010</year>
<volume>362</volume>
<fpage>2389</fpage>
<lpage>2398</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMcp1000274</pub-id>
<?supplied-pmid 20573927?><pub-id pub-id-type="pmid">20573927</pub-id></element-citation></ref><ref id="B65-ijms-17-00093"><label>65.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berkley</surname><given-names>K.J.</given-names></name><name><surname>Rapkin</surname><given-names>A.J.</given-names></name><name><surname>Papka</surname><given-names>R.E.</given-names></name></person-group>
<article-title>The pains of endometriosis</article-title>
<source>Science</source>
<year>2005</year>
<volume>308</volume>
<fpage>1587</fpage>
<lpage>1589</lpage>
<pub-id pub-id-type="doi">10.1126/science.1111445</pub-id>
<?supplied-pmid 15947176?><pub-id pub-id-type="pmid">15947176</pub-id></element-citation></ref><ref id="B66-ijms-17-00093"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stilley</surname><given-names>J.A.</given-names></name><name><surname>Birt</surname><given-names>J.A.</given-names></name><name><surname>Sharpe-Timms</surname><given-names>K.L.</given-names></name></person-group>
<article-title>Cellular and molecular basis for endometriosis-associated infertility</article-title>
<source>Cell Tissue Res.</source>
<year>2012</year>
<volume>349</volume>
<fpage>849</fpage>
<lpage>862</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-011-1309-0</pub-id>
<?supplied-pmid 22298022?><pub-id pub-id-type="pmid">22298022</pub-id></element-citation></ref><ref id="B67-ijms-17-00093"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giudice</surname><given-names>L.C.</given-names></name><name><surname>Kao</surname><given-names>L.C.</given-names></name></person-group>
<article-title>Endometriosis</article-title>
<source>Lancet</source>
<year>2004</year>
<volume>364</volume>
<fpage>1789</fpage>
<lpage>1799</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(04)17403-5</pub-id>
<pub-id pub-id-type="pmid">15541453</pub-id></element-citation></ref><ref id="B68-ijms-17-00093"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scully</surname><given-names>R.E.</given-names></name></person-group>
<article-title>Classification of human ovarian tumors</article-title>
<source>Environ. Health Perspect.</source>
<year>1987</year>
<volume>73</volume>
<fpage>15</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.877315</pub-id>
<?supplied-pmid 3665859?><pub-id pub-id-type="pmid">3665859</pub-id></element-citation></ref><ref id="B69-ijms-17-00093"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>S.W.</given-names></name></person-group>
<article-title>Endometriosis and ovarian cancer: Potential benefits and harms of screening and risk-reducing surgery</article-title>
<source>Fertil. Steril.</source>
<year>2015</year>
<volume>104</volume>
<fpage>813</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2015.08.006</pub-id>
<?supplied-pmid 26335131?><pub-id pub-id-type="pmid">26335131</pub-id></element-citation></ref><ref id="B70-ijms-17-00093"><label>70.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampson</surname><given-names>J.</given-names></name></person-group>
<article-title>Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ</article-title>
<source>Arch. Surg.</source>
<year>1925</year>
<volume>10</volume>
<fpage>1</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1001/archsurg.1925.01120100007001</pub-id>
</element-citation></ref><ref id="B71-ijms-17-00093"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wei</surname><given-names>J.J.</given-names></name><name><surname>William</surname><given-names>J.</given-names></name><name><surname>Bulun</surname><given-names>S.</given-names></name></person-group>
<article-title>Endometriosis and ovarian cancer: A review of clinical, pathologic, and molecular aspects</article-title>
<source>Int. J. Gynecol. Pathol.</source>
<year>2011</year>
<volume>30</volume>
<fpage>553</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1097/PGP.0b013e31821f4b85</pub-id>
<?supplied-pmid 21979592?><pub-id pub-id-type="pmid">21979592</pub-id></element-citation></ref><ref id="B72-ijms-17-00093"><label>72.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Munksgaard</surname><given-names>P.S.</given-names></name><name><surname>Blaakaer</surname><given-names>J.</given-names></name></person-group>
<article-title>The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations</article-title>
<source>Gynecol. Oncol.</source>
<year>2012</year>
<volume>124</volume>
<fpage>164</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1016/j.ygyno.2011.10.001</pub-id>
<?supplied-pmid 22032835?><pub-id pub-id-type="pmid">22032835</pub-id></element-citation></ref><ref id="B73-ijms-17-00093"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Worley</surname><given-names>M.J.</given-names></name><name><surname>Welch</surname><given-names>W.R.</given-names></name><name><surname>Berkowitz</surname><given-names>R.S.</given-names></name><name><surname>Ng</surname><given-names>S.W.</given-names></name></person-group>
<article-title>Endometriosis-associated ovarian cancer: A review of pathogenesis</article-title>
<source>Int. J. Mol. Sci.</source>
<year>2013</year>
<volume>14</volume>
<fpage>5367</fpage>
<lpage>5379</lpage>
<pub-id pub-id-type="doi">10.3390/ijms14035367</pub-id>
<?supplied-pmid 23466883?><pub-id pub-id-type="pmid">23466883</pub-id></element-citation></ref><ref id="B74-ijms-17-00093"><label>74.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Siufi-Neto</surname><given-names>J.</given-names></name><name><surname>Kho</surname><given-names>R.M.</given-names></name><name><surname>Siufi</surname><given-names>D.F.</given-names></name><name><surname>Baracat</surname><given-names>E.C.</given-names></name><name><surname>Anderson</surname><given-names>K.S.</given-names></name><name><surname>Abr&#x000e3;o</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer</article-title>
<source>J. Minim. Invasive Gynecol.</source>
<year>2014</year>
<volume>21</volume>
<fpage>55</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmig.2013.07.021</pub-id>
<?supplied-pmid 23962574?><pub-id pub-id-type="pmid">23962574</pub-id></element-citation></ref><ref id="B75-ijms-17-00093"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burney</surname><given-names>R.O.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name></person-group>
<article-title>Pathogenesis and pathophysiology of endometriosis</article-title>
<source>Fertil. Steril.</source>
<year>2012</year>
<volume>98</volume>
<fpage>511</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2012.06.029</pub-id>
<?supplied-pmid 22819144?><pub-id pub-id-type="pmid">22819144</pub-id></element-citation></ref><ref id="B76-ijms-17-00093"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dunselman</surname><given-names>G.A.</given-names></name><name><surname>Vermeulen</surname><given-names>N.</given-names></name><name><surname>Becker</surname><given-names>C.</given-names></name><name><surname>Calhaz-Jorge</surname><given-names>C.</given-names></name><name><surname>D'Hooghe</surname><given-names>T.</given-names></name><name><surname>De Bie</surname><given-names>B.</given-names></name><name><surname>Heikinheimo</surname><given-names>O.</given-names></name><name><surname>Horne</surname><given-names>A.W.</given-names></name><name><surname>Kiesel</surname><given-names>L.</given-names></name><name><surname>Nap</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>European Society of Human Reproduction and Embryology. ESHRE guideline: Management of women with endometriosis</article-title>
<source>Hum. Reprod.</source>
<year>2014</year>
<volume>29</volume>
<fpage>400</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/det457</pub-id>
<?supplied-pmid 24435778?><pub-id pub-id-type="pmid">24435778</pub-id></element-citation></ref><ref id="B77-ijms-17-00093"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ballard</surname><given-names>K.</given-names></name><name><surname>Lowton</surname><given-names>K.</given-names></name><name><surname>Wright</surname><given-names>J.</given-names></name></person-group>
<article-title>What&#x02019;s the delay? A qualitative study of women&#x02019;s experiences of reaching a diagnosis of endometriosis</article-title>
<source>Fertil. Steril.</source>
<year>2006</year>
<volume>86</volume>
<fpage>1296</fpage>
<lpage>1301</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2006.04.054</pub-id>
<?supplied-pmid 17070183?><pub-id pub-id-type="pmid">17070183</pub-id></element-citation></ref><ref id="B78-ijms-17-00093"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fassbender</surname><given-names>A.</given-names></name><name><surname>Vodolazkaia</surname><given-names>A.</given-names></name><name><surname>Saunders</surname><given-names>P.</given-names></name><name><surname>Lebovic</surname><given-names>D.</given-names></name><name><surname>Waelkens</surname><given-names>E.</given-names></name><name><surname>De Moor</surname><given-names>B.</given-names></name><name><surname>D&#x02019;Hooghe</surname><given-names>T.</given-names></name></person-group>
<article-title>Biomarkers of endometriosis</article-title>
<source>Fertil. Steril.</source>
<year>2013</year>
<volume>99</volume>
<fpage>1135</fpage>
<lpage>1145</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2013.01.097</pub-id>
<?supplied-pmid 23414923?><pub-id pub-id-type="pmid">23414923</pub-id></element-citation></ref><ref id="B79-ijms-17-00093"><label>79.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D&#x02019;Hooghe</surname><given-names>T.M.</given-names></name><name><surname>Debrock</surname><given-names>S.</given-names></name></person-group>
<article-title>Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons</article-title>
<source>Hum. Reprod. Update</source>
<year>2002</year>
<volume>8</volume>
<fpage>84</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1093/humupd/8.1.84</pub-id>
<?supplied-pmid 11866244?><pub-id pub-id-type="pmid">11866244</pub-id></element-citation></ref><ref id="B80-ijms-17-00093"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nnoaham</surname><given-names>K.E.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>Kennedy</surname><given-names>S.H.</given-names></name><name><surname>Jenkinson</surname><given-names>C.</given-names></name><name><surname>Zondervan</surname><given-names>K.T.</given-names></name></person-group>
<article-title>Developing symptom-based predictive models of endometriosis as a clinical screening tool: Results from a multicenter study</article-title>
<source>Fertil. Steril.</source>
<year>2012</year>
<volume>98</volume>
<fpage>692</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2012.04.022</pub-id>
<?supplied-pmid 22657249?><pub-id pub-id-type="pmid">22657249</pub-id></element-citation></ref><ref id="B81-ijms-17-00093"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jia</surname><given-names>S.Z.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Lang</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Leng</surname><given-names>J.</given-names></name></person-group>
<article-title>Plasma miR-17&#x02013;5p, miR-20a and miR-22 are down-regulated in women with endometriosis</article-title>
<source>Hum. Reprod.</source>
<year>2013</year>
<volume>28</volume>
<fpage>322</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/des413</pub-id>
<?supplied-pmid 23203215?><pub-id pub-id-type="pmid">23203215</pub-id></element-citation></ref><ref id="B82-ijms-17-00093"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cho</surname><given-names>S.</given-names></name><name><surname>Mutlu</surname><given-names>L.</given-names></name><name><surname>Grechukhina</surname><given-names>O.</given-names></name><name><surname>Taylor</surname><given-names>H.S.</given-names></name></person-group>
<article-title>Circulating microRNAs as potential biomarkers for endometriosis</article-title>
<source>Fertil. Steril.</source>
<year>2015</year>
<volume>103</volume>
<fpage>1252</fpage>
<lpage>1260</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2015.02.013</pub-id>
<?supplied-pmid 25772772?><pub-id pub-id-type="pmid">25772772</pub-id></element-citation></ref><ref id="B83-ijms-17-00093"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rekker</surname><given-names>K.</given-names></name><name><surname>Saare</surname><given-names>M.</given-names></name><name><surname>Roost</surname><given-names>A.M.</given-names></name><name><surname>Kaart</surname><given-names>T.</given-names></name><name><surname>S&#x000f5;ritsa</surname><given-names>D.</given-names></name><name><surname>Karro</surname><given-names>H.</given-names></name><name><surname>S&#x000f5;ritsa</surname><given-names>A.</given-names></name><name><surname>Sim&#x000f3;n</surname><given-names>C.</given-names></name><name><surname>Salumets</surname><given-names>A.</given-names></name><name><surname>Peters</surname><given-names>M.</given-names></name></person-group>
<article-title>Circulating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time</article-title>
<source>Fertil. Steril.</source>
<year>2015</year>
<volume>104</volume>
<fpage>938</fpage>
<lpage>946</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2015.06.029</pub-id>
<?supplied-pmid 26206343?><pub-id pub-id-type="pmid">26206343</pub-id></element-citation></ref><ref id="B84-ijms-17-00093"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rogers</surname><given-names>P.A.</given-names></name><name><surname>D'Hooghe</surname><given-names>T.M.</given-names></name><name><surname>Fazleabas</surname><given-names>A.</given-names></name><name><surname>Gargett</surname><given-names>C.E.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name><name><surname>Montgomery</surname><given-names>G.W.</given-names></name><name><surname>Rombauts</surname><given-names>L.</given-names></name><name><surname>Salamonsen</surname><given-names>L.A.</given-names></name><name><surname>Zondervan</surname><given-names>K.T.</given-names></name></person-group>
<article-title>Priorities for endometriosis research: Recommendations from an international consensus workshop</article-title>
<source>Reprod. Sci.</source>
<year>2009</year>
<volume>16</volume>
<fpage>335</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1177/1933719108330568</pub-id>
<?supplied-pmid 19196878?><pub-id pub-id-type="pmid">19196878</pub-id></element-citation></ref><ref id="B85-ijms-17-00093"><label>85.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Halme</surname><given-names>J.</given-names></name><name><surname>Hammond</surname><given-names>M.G.</given-names></name><name><surname>Hulka</surname><given-names>J.F.</given-names></name><name><surname>Raj</surname><given-names>S.G.</given-names></name><name><surname>Talbert</surname><given-names>L.M.</given-names></name></person-group>
<article-title>Retrograde menstruation in healthy women and in patients with endometriosis</article-title>
<source>Obstet. Gynecol.</source>
<year>1984</year>
<volume>64</volume>
<fpage>151</fpage>
<lpage>154</lpage>
<?supplied-pmid 6234483?><pub-id pub-id-type="pmid">6234483</pub-id></element-citation></ref><ref id="B86-ijms-17-00093"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Filigheddu</surname><given-names>N.</given-names></name><name><surname>Gregnanin</surname><given-names>I.</given-names></name><name><surname>Porporato</surname><given-names>P.</given-names></name><name><surname>Surico</surname><given-names>D.</given-names></name><name><surname>Perego</surname><given-names>B.</given-names></name><name><surname>Galli</surname><given-names>L.</given-names></name><name><surname>Patrignani</surname><given-names>C.</given-names></name><name><surname>Graziani</surname><given-names>A.</given-names></name><name><surname>Surico</surname><given-names>N.</given-names></name></person-group>
<article-title>Differential expression of micrornas between eutopic and ectopic endometrium in ovarian endometriosis</article-title>
<source>J. Biomed. Biotechnol.</source>
<year>2010</year>
<volume>2010</volume>
<fpage>369549</fpage>
<pub-id pub-id-type="doi">10.1155/2010/369549</pub-id>
<?supplied-pmid 20300586?><pub-id pub-id-type="pmid">20300586</pub-id></element-citation></ref><ref id="B87-ijms-17-00093"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laudanski</surname><given-names>P.</given-names></name><name><surname>Charkiewicz</surname><given-names>R.</given-names></name><name><surname>Kuzmicki</surname><given-names>M.</given-names></name><name><surname>Szamatowicz</surname><given-names>J.</given-names></name><name><surname>Charkiewicz</surname><given-names>A.</given-names></name><name><surname>Niklinski</surname><given-names>J.</given-names></name></person-group>
<article-title>MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis</article-title>
<source>Reprod. Biol. Endocrinol.</source>
<year>2013</year>
<volume>11</volume>
<fpage>78</fpage>
<pub-id pub-id-type="doi">10.1186/1477-7827-11-78</pub-id>
<?supplied-pmid 23945042?><pub-id pub-id-type="pmid">23945042</pub-id></element-citation></ref><ref id="B88-ijms-17-00093"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Houshdaran</surname><given-names>S.</given-names></name><name><surname>Zelenko</surname><given-names>Z.</given-names></name><name><surname>Irwin</surname><given-names>J.C.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name></person-group>
<article-title>Human endometrial DNA methylome is cycle-dependent and is associated with gene expression regulation</article-title>
<source>Mol. Endocrinol.</source>
<year>2014</year>
<volume>28</volume>
<fpage>1118</fpage>
<lpage>1135</lpage>
<pub-id pub-id-type="doi">10.1210/me.2013-1340</pub-id>
<?supplied-pmid 24877562?><pub-id pub-id-type="pmid">24877562</pub-id></element-citation></ref><ref id="B89-ijms-17-00093"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Munro</surname><given-names>S.K.</given-names></name><name><surname>Farquhar</surname><given-names>C.M.</given-names></name><name><surname>Mitchell</surname><given-names>M.D.</given-names></name><name><surname>Ponnampalam</surname><given-names>A.P.</given-names></name></person-group>
<article-title>Epigenetic regulation of endometrium during the menstrual cycle</article-title>
<source>Mol. Hum. Reprod.</source>
<year>2010</year>
<volume>16</volume>
<fpage>297</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1093/molehr/gaq010</pub-id>
<?supplied-pmid 20139117?><pub-id pub-id-type="pmid">20139117</pub-id></element-citation></ref><ref id="B90-ijms-17-00093"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harada</surname><given-names>T.</given-names></name><name><surname>Kaponis</surname><given-names>A.</given-names></name><name><surname>Iwabe</surname><given-names>T.</given-names></name><name><surname>Taniguchi</surname><given-names>F.</given-names></name><name><surname>Makrydimas</surname><given-names>G.</given-names></name><name><surname>Sofikitis</surname><given-names>N.</given-names></name><name><surname>Paschopoulos</surname><given-names>M.</given-names></name><name><surname>Paraskevaidis</surname><given-names>E.</given-names></name><name><surname>Terakawa</surname><given-names>N.</given-names></name></person-group>
<article-title>Apoptosis in human endometrium and endometriosis</article-title>
<source>Hum. Reprod. Update</source>
<year>2004</year>
<volume>10</volume>
<fpage>29</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1093/humupd/dmh007</pub-id>
<?supplied-pmid 15005462?><pub-id pub-id-type="pmid">15005462</pub-id></element-citation></ref><ref id="B91-ijms-17-00093"><label>91.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rocha</surname><given-names>A.L.</given-names></name><name><surname>Reis</surname><given-names>F.M.</given-names></name><name><surname>Taylor</surname><given-names>R.N.</given-names></name></person-group>
<article-title>Angiogenesis and endometriosis</article-title>
<source>Obstet. Gynecol. Int.</source>
<year>2013</year>
<volume>2013</volume>
<fpage>859619</fpage>
<pub-id pub-id-type="doi">10.1155/2013/859619</pub-id>
<?supplied-pmid 23766765?><pub-id pub-id-type="pmid">23766765</pub-id></element-citation></ref><ref id="B92-ijms-17-00093"><label>92.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laschke</surname><given-names>M.W.</given-names></name><name><surname>Menger</surname><given-names>M.D.</given-names></name></person-group>
<article-title><italic>In vitro</italic> and <italic>in vivo</italic> approaches to study angiogenesis in the pathophysiology and therapy of endometriosis</article-title>
<source>Hum. Reprod. Update</source>
<year>2007</year>
<volume>13</volume>
<fpage>331</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1093/humupd/dmm006</pub-id>
<?supplied-pmid 17347159?><pub-id pub-id-type="pmid">17347159</pub-id></element-citation></ref><ref id="B93-ijms-17-00093"><label>93.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilabert-Estelles</surname><given-names>J.</given-names></name><name><surname>Estelles</surname><given-names>A.</given-names></name><name><surname>Gilabert</surname><given-names>J.</given-names></name><name><surname>Castell&#x000f3;</surname><given-names>R.</given-names></name><name><surname>Espa&#x000f1;a</surname><given-names>F.</given-names></name><name><surname>Falc&#x000f3;</surname><given-names>C.</given-names></name><name><surname>Romeu</surname><given-names>A.</given-names></name><name><surname>Chirivella</surname><given-names>M.</given-names></name><name><surname>Zorio</surname><given-names>E.</given-names></name><name><surname>Aznar</surname><given-names>J.</given-names></name></person-group>
<article-title>Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis</article-title>
<source>Hum. Reprod.</source>
<year>2003</year>
<volume>18</volume>
<fpage>1516</fpage>
<lpage>1522</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/deg300</pub-id>
<?supplied-pmid 12832381?><pub-id pub-id-type="pmid">12832381</pub-id></element-citation></ref><ref id="B94-ijms-17-00093"><label>94.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilabert-Estelles</surname><given-names>J.</given-names></name><name><surname>Ramon</surname><given-names>L.A.</given-names></name><name><surname>Espana</surname><given-names>F.</given-names></name><name><surname>Gilabert</surname><given-names>J.</given-names></name><name><surname>Vila</surname><given-names>V.</given-names></name><name><surname>R&#x000e9;ganon</surname><given-names>E.</given-names></name><name><surname>Castell&#x000f3;</surname><given-names>R.</given-names></name><name><surname>Chirivella</surname><given-names>M.</given-names></name><name><surname>Estell&#x000e9;s</surname><given-names>A.</given-names></name></person-group>
<article-title>Expression of angiogenic factors in endometriosis: Its relation to fibrinolytic and metalloproteinase (MMP) systems</article-title>
<source>Hum. Reprod.</source>
<year>2007</year>
<volume>22</volume>
<fpage>2120</fpage>
<lpage>2127</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/dem149</pub-id>
<?supplied-pmid 17609243?><pub-id pub-id-type="pmid">17609243</pub-id></element-citation></ref><ref id="B95-ijms-17-00093"><label>95.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caporali</surname><given-names>A.</given-names></name><name><surname>Emanueli</surname><given-names>C.</given-names></name></person-group>
<article-title>MicroRNA regulation in angiogenesis</article-title>
<source>Vascul. Pharmacol.</source>
<year>2011</year>
<volume>55</volume>
<fpage>79</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1016/j.vph.2011.06.006</pub-id>
<?supplied-pmid 21777698?><pub-id pub-id-type="pmid">21777698</pub-id></element-citation></ref><ref id="B96-ijms-17-00093"><label>96.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braza-Boils</surname><given-names>A.</given-names></name><name><surname>Salloum-Asfar</surname><given-names>S.</given-names></name><name><surname>Mar&#x000ed;-Alexandre</surname><given-names>J.</given-names></name><name><surname>Arroyo</surname><given-names>A.B.</given-names></name><name><surname>Gonz&#x000e1;lez-Conejero</surname><given-names>R.</given-names></name><name><surname>Barcel&#x000f3;-Molina</surname><given-names>M.</given-names></name><name><surname>Garc&#x000ed;a-Oms</surname><given-names>J.</given-names></name><name><surname>Vicente</surname><given-names>V.</given-names></name><name><surname>Estell&#x000e9;s</surname><given-names>A.</given-names></name><name><surname>Gilabert-Estell&#x000e9;s</surname><given-names>J.</given-names></name><etal/></person-group>
<article-title>Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis</article-title>
<source>Hum. Reprod.</source>
<year>2015</year>
<volume>30</volume>
<fpage>2292</fpage>
<lpage>2302</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/dev204</pub-id>
<?supplied-pmid 26307093?><pub-id pub-id-type="pmid">26307093</pub-id></element-citation></ref><ref id="B97-ijms-17-00093"><label>97.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olive</surname><given-names>V.</given-names></name><name><surname>Jiang</surname><given-names>I.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name></person-group>
<article-title>mir-17&#x02013;92, a cluster of miRNAs in the midst of the cancer network</article-title>
<source>Int. J. Biochem. Cell Biol.</source>
<year>2010</year>
<volume>42</volume>
<fpage>1348</fpage>
<lpage>1354</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2010.03.004</pub-id>
<?supplied-pmid 20227518?><pub-id pub-id-type="pmid">20227518</pub-id></element-citation></ref><ref id="B98-ijms-17-00093"><label>98.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braza-Bo&#x000ef;ls</surname><given-names>A.</given-names></name><name><surname>Gilabert-Estell&#x000e9;s</surname><given-names>J.</given-names></name><name><surname>Ram&#x000f3;n</surname><given-names>L.A.</given-names></name><name><surname>Gilabert</surname><given-names>J.</given-names></name><name><surname>Mar&#x000ed;-Alexandre</surname><given-names>J.</given-names></name><name><surname>Chirivella</surname><given-names>M.</given-names></name><name><surname>Espa&#x000f1;a</surname><given-names>F.</given-names></name><name><surname>Estell&#x000e9;s</surname><given-names>A.</given-names></name></person-group>
<article-title>Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis</article-title>
<source>PLoS ONE</source>
<year>2013</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0062370</pub-id>
<?supplied-pmid 23620826?><pub-id pub-id-type="pmid">23620826</pub-id></element-citation></ref><ref id="B99-ijms-17-00093"><label>99.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.T.</given-names></name><name><surname>Zhao</surname><given-names>Y.N.</given-names></name><name><surname>Han</surname><given-names>B.W.</given-names></name><name><surname>Hong</surname><given-names>S.J.</given-names></name><name><surname>Chen</surname><given-names>Y.Q.</given-names></name></person-group>
<article-title>Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis</article-title>
<source>J. Clin. Endocrinol. Metab.</source>
<year>2013</year>
<volume>98</volume>
<fpage>281</fpage>
<lpage>289</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2012-2415</pub-id>
<?supplied-pmid 23118427?><pub-id pub-id-type="pmid">23118427</pub-id></element-citation></ref><ref id="B100-ijms-17-00093"><label>100.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rekker</surname><given-names>K.</given-names></name><name><surname>Saare</surname><given-names>M.</given-names></name><name><surname>Roost</surname><given-names>A.M.</given-names></name><name><surname>Salumets</surname><given-names>A.</given-names></name><name><surname>Peters</surname><given-names>M.</given-names></name></person-group>
<article-title>Circulating microRNA profile throughout the menstrual cycle</article-title>
<source>PLoS ONE</source>
<year>2013</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0081166</pub-id>
<?supplied-pmid 24244734?><pub-id pub-id-type="pmid">24244734</pub-id></element-citation></ref><ref id="B101-ijms-17-00093"><label>101.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Becker</surname><given-names>C.M.</given-names></name><name><surname>Laufer</surname><given-names>M.R.</given-names></name><name><surname>Stratton</surname><given-names>P.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>Missmer</surname><given-names>S.A.</given-names></name><name><surname>Zondervan</surname><given-names>K.T.</given-names></name><name><surname>Adamson</surname><given-names>G.D.</given-names></name><collab>WERF EPHect Working Group.</collab></person-group>
<article-title>World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research</article-title>
<source>Fertil. Steril.</source>
<year>2014</year>
<volume>102</volume>
<fpage>1213</fpage>
<lpage>1222</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.07.709</pub-id>
<?supplied-pmid 25150390?><pub-id pub-id-type="pmid">25150390</pub-id></element-citation></ref><ref id="B102-ijms-17-00093"><label>102.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vitonis</surname><given-names>A.F.</given-names></name><name><surname>Vincent</surname><given-names>K.</given-names></name><name><surname>Rahmioglu</surname><given-names>N.</given-names></name><name><surname>Fassbender</surname><given-names>A.</given-names></name><name><surname>Buck Louis</surname><given-names>G.M.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name><name><surname>Stratton</surname><given-names>P.</given-names></name><name><surname>Adamson</surname><given-names>G.D.</given-names></name><name><surname>Becker</surname><given-names>C.M.</given-names></name><etal/></person-group>
<article-title>World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research</article-title>
<source>Fertil. Steril.</source>
<year>2014</year>
<volume>102</volume>
<fpage>1223</fpage>
<lpage>1232</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.07.1244</pub-id>
<?supplied-pmid 25256930?><pub-id pub-id-type="pmid">25256930</pub-id></element-citation></ref><ref id="B103-ijms-17-00093"><label>103.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahmioglu</surname><given-names>N.</given-names></name><name><surname>Fassbender</surname><given-names>A.</given-names></name><name><surname>Vitonis</surname><given-names>A.F.</given-names></name><name><surname>Tworoger</surname><given-names>S.S.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>D'Hooghe</surname><given-names>T.M.</given-names></name><name><surname>Adamson</surname><given-names>G.D.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name><name><surname>Becker</surname><given-names>C.M.</given-names></name><name><surname>Zondervan</surname><given-names>K.T.</given-names></name><etal/></person-group>
<article-title>World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research</article-title>
<source>Fertil. Steril.</source>
<year>2014</year>
<volume>102</volume>
<fpage>1233</fpage>
<lpage>1243</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.07.1208</pub-id>
<?supplied-pmid 25256929?><pub-id pub-id-type="pmid">25256929</pub-id></element-citation></ref><ref id="B104-ijms-17-00093"><label>104.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fassbender</surname><given-names>A.</given-names></name><name><surname>Rahmioglu</surname><given-names>N.</given-names></name><name><surname>Vitonis</surname><given-names>A.F.</given-names></name><name><surname>Vigan&#x000f2;</surname><given-names>P.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name><name><surname>D&#x02019;Hooghe</surname><given-names>T.M.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>Adamson</surname><given-names>G.D.</given-names></name><name><surname>Becker</surname><given-names>C.M.</given-names></name><name><surname>Missmer</surname><given-names>S.A.</given-names></name><etal/></person-group>
<article-title>World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research</article-title>
<source>Fertil. Steril.</source>
<year>2014</year>
<volume>102</volume>
<fpage>1244</fpage>
<lpage>1253</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.07.1209</pub-id>
<?supplied-pmid 25256928?><pub-id pub-id-type="pmid">25256928</pub-id></element-citation></ref></ref-list></back></article>